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Titanium medical implants have revolutionized health care in treating bone and joint degeneration, 
neoplasms and inflammation1. Due to their biocompatibility, mechanical strength, and non-
corrosive properties, titanium and titanium alloys are among the most common materials used in 
medical and dental implants2-5. Despite improvements in implant technology, including 
prophylactic therapy, failure attributed to infection is as high as 7.5% of total hip arthroplasty, 
14.8% of total knee arthroplasty6,7, and 8% of dental implants8-10. In the first hours following 
surgery the implant surface is most vulnerable to bacterial colonization and the bacterial pathogens 
are also most susceptible to antimicrobial treatment11,12. We demonstrate the design and 
application of a bifunctional peptide film composed of a titanium anchoring domain linked to an 
antimicrobial peptide domain through an engineered spacer for prevention and treatment of 
medical implant infections. To overcome challenges with preserving anchoring and antimicrobial 
domain function, we propose a spacer design to reduce inter-domain interference and improve 
function based on understanding the peptide structure/function relationship. This innovative 
approach overcomes challenges faced with rising numbers of antibiotic resistance bacterial strains, 
by providing a localized and robust antimicrobial and antifouling effect. Our studies aim to 
enhance the bifunctional peptide design by incorporating different functional domains using a 
predictive design approach. Along with these studies, we designed peptides based upon structure-
function relationship, characterized their individual functions, and proposed design criteria for 
effective surface functionalization of the peptide films. Finally, we test the proposed approach as 
a retreatment option for various stages of peri-implant disease, which is a major unsolved problem 
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CHAPTER 1 - INTRODUCTION TO THESIS 
 
The overall objective of this thesis is to develop a bio-enabled peptide film 
approach to combat implant failure by designing an engineered bifunctional peptide film 
that anchors to titanium and brings antimicrobial function to the implant surface as a 
treatment for orthopedic and dental implant infections and resulting diseases such as peri-
implantitis. We note bifunctional design has a tremendous effect on the overall function of 
the peptide film when an implant binding peptide is combined to a bioactive peptide 
domain such as an antimicrobial peptide (AMP). Development of an understanding of the 
sequence-structure-function relationship of bifunctional peptides represents a significant 
addition to the current body of work and the opportunity to advance the development of 
biointerfaces on medical implants that are effective at combating bacterial colonization 
leading to infection while supporting host cell attachment and viability.  
The overall progression of this thesis was accomplished in three specific aims. 
These aims were published in three peer-reviewed articles that are reproduced in this thesis 
as Chapter 2, Chapter 3, and Chapter 4. Chapter 5 summarizes the key findings of this body 
of work as a whole.  
The first aim was to design and engineer the spacer in bifunctional peptides. Peptide 
secondary structure is closely linked to function. Thus, preservation of the secondary 
structure of the functional domains is critical for peptide engineering. In Chapter 2, we 
build upon the work on bifunctional peptides previously reported by our group and 
incorporate a novel spacer design engineered to improve the antimicrobial domain function 
while maintaining attachment of the titanium binding peptide (TiBP) to the implant surface. 
In this chapter we report an improvement of antimicrobial function of the bifunctional 
peptide film applied to titanium foils and orthopedic implants against two bacterial strains, 
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S. mutans and S. epidermidis. Further, the bifunctional peptide film was evaluated for host 
cell response using fibroblast cells. The improved function associated with the novel spacer 
design was related to “rules” developed by our group for bifunctional peptide design.  
The second aim was the design of novel bifunctional peptides. The body of 
literature identifying naturally occurring AMP domains, as well as efforts to 
computationally search for novel sequences is rapidly growing. Several databases have 
been assembled to house AMP sequences. Deploying these antimicrobials to combat 
implant infection requires engineering of the bifunctional peptide platform to demonstrate 
the feasibility of incorporating additional AMPs. Incorporation of additional AMPs offers 
the opportunity to improve antimicrobial function of the bifunctional peptide film with the 
potential to further extend the bifunctional peptide film efficacy to a broad spectrum of 
bacteria. In Chapter 3, we report a design approach for bifunctional peptides using less 
resource intensive methods to evaluate the bifunctional peptide contributions of amino 
acids in the sequence, peptide secondary structure features, and backbone dynamics. This 
design approach was used to design two additional bifunctional peptides by incorporating 
AMP sequences from the literature and available databases. We report computational and 
experimental structural analysis, bifunctional peptide binding on a clinically relevant time 
scale and in the presence of competing serum proteins, quantify the antimicrobial effect 
and evaluate the durability of the bifunctional peptide film. This is done while relating the 
sequence-structure-function relationships in the bifunctional peptide engineering. 
The third aim was to demonstrate in vitro the treatment and retreatment of peri-
implant disease using a bifunctional peptide film. Delivery of a bifunctional peptide film 
to dental implants represents a non-surgical, green technology approach to improve oral 
health and reduce peri-implant disease progression. In Chapter 4, we demonstrated the 
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bifunctional peptide film as a water-based, non-surgical strategy that can be reapplied 
during recall appointments for treatment of peri-implant disease. We demonstrate the 
reapplication of the bifunctional peptide film with effective antimicrobial function 
following four successive bacterial fouling and cleaning cycles. 
In Chapter 5, we provide concluding remarks and summarize key findings from the 
thesis as a whole. This work represents a paradigm shift in the prevention of implant failure 
while adding to the range of bioactive molecules that can be anchored to implant surfaces 
to improve implant longevity and effectiveness in restoring function to the body. Further 
efforts in this direction have great promise in providing treatment alternatives to traditional 
antibiotic therapies as the number of antibiotic resistant bacterial strains are increasing, 




CHAPTER 2 - CONTROLLING THE BIOMIMETIC IMPLANT INTERFACE: 
MODULATING ANTIMICROBIAL ACTIVITY BY SPACER DESIGN * 
 
ABSTRACT 
Morbidity progressing to failure remains a challenge for surgical placement of 
titanium implants due to surface bacterial infection that initiates a host inflammatory 
response leading to implant loosening and ultimately requiring revision surgery. Since 
implant failure starts at the implant surface, creating and controlling the bio-material 
interface will play a critical role in reducing infection while improving host cell-to implant 
interaction. Here, we engineered a biomimetic interface based upon a chimeric peptide that 
incorporates a titanium binding peptide (TiBP) with an antimicrobial peptide (AMP) into 
a single molecule to direct binding to the implant surface and deliver an antimicrobial 
activity against S. mutans and S. epidermidis, two bacteria which are linked with clinical 
implant infections. To optimize antimicrobial activity, we investigated the design of the 
spacer domain separating the two functional domains of the chimeric peptide. Lengthening 
and changing the amino acid composition of the spacer resulted in a 3-fold MIC 
improvement against S. mutans. Surfaces coated with the chimeric peptide showed 
dramatically reduced bacteria numbers, with up to a 9-fold reduction for S. mutans and a 
48-fold reduction for S. epidermidis. Ab initio predictions of antimicrobial activity based 
                                               
 
 
* Wisdom C, VanOosten, S.K., Boone, K.W., Khvostenko, D., Arnold, P.M., Snead, 
M.L., and Tamerler, C. Controlling the Biomimetic Implant Interface: Modulating 




on structural features were confirmed. Host cell attachment and viability at the biomimetic 
interface were also improved compared to the untreated implant surface. Biomimetic 
interfaces formed with this chimeric peptide offer interminable potential by coupling 
antimicrobial and improved host cell responses to implantable titanium materials, and 







Bone and joint implants have revolutionized the healthcare of aging patients whose 
life expectancy has been increasing.1 Implants have been intensively used during the last 
40 years in treating bone and joint degeneration, neoplasms and inflammation.1 Titanium 
and titanium alloys are used as implant biomaterials due to their biocompatibility, 
mechanical strength, and non-corrosive properties.2-5 However, nosocomial microbial 
attachment to the implant surface can result in infection and inflammation with loosening 
that requires surgical revision. In the first hours following surgery the implant surface is 
most vulnerable to bacterial colonization and the bacterial pathogens are also most 
susceptible to antimicrobial treatment.11,12 With time, bacteria populations multiply and 
cooperate to form biofilms that function as natural barriers against antibiotic 
effectiveness.13 Treatment for infection of this type is difficult and the revision surgery is 
more complex, adding to patient morbidity. Despite improvements in implant technology 
including prophylactic therapy, most implant failures can be attributed to either infection 
or aseptic loosening resulting from poor integration with host tissue.6,7 Failure requiring 
revision surgery is caused by infection in 7.5% of total hip arthroplasty (THA) and 14.8% 
of total knee arthroplasty (TKA) and by aseptic loosening in 55.2% of THA and 29.8% of 
TKA.14 Immediate prevention of bacterial attachment on the implant surface is critical in 
prevention of infection related failure. However, host cell attachment and viability at the 
interface is also critical to host bone integration to prevent implant loosening. Therefore, 
an imperative clinical need exists to prevent bacterial colonization on the implant surface 
while not negatively affecting host cell response that could lead to poor integration of the 
implant material with the host. An implant surface with a fast-acting, broad-spectrum 
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antimicrobial function prevents bacterial attachment to reduce biofilm formation while 
maintaining implant integration with the host tissue would prove to be a paradigm shift. 
Multiple strategies have been developed with the aim of eliminating microbial 
attachment on the implant surface. Among them, the use of antibiotics has been commonly 
employed in daily practice. However the rise of antibiotic resistance is becoming a major 
concern in dealing with bacteria, which also led to an increase in efforts to find alternative 
strategies.2-5 Silver, polyethylene glycol (PEG), or quaternary ammonia based compounds 
(QACs) have been among the well-studied examples to bring the antimicrobial property by 
attaching them to the biomaterials using covalent chemical bonds.15-20 Another strategy is 
to improve the antibacterial properties of metals by doping them with elements such as 
bismuth and zinc.21,22 While promising, chemistry based immobilizations require complex 
steps, which may be not favorable within the biological environment due to their harshness. 
Additionally, uniform coatings where bioactivity is both preserved and homogenously 
distributed throughout the biomaterial surface following their coupling onto the 
biomaterials are challenging to obtain.  
Another strategy is to coat the surface with antimicrobial peptides (AMPs). AMPs 
are abundant in nature and employed as natural innate immune system defense fighters. 
AMPs are fast-acting antimicrobial agents that are effective against a broad spectrum of 
gram-positive bacteria, gram-negative bacteria, viruses and fungi.23-25 AMPs offer an 
alternative to conventional antibiotics to which some pathogens develop resistance more 
readily.26 However, with the current technologies available, AMPs can be covalently 
immobilize onto the implant surfaces, and covalently immobilization of biomolecules have 
also proven to be less effective due to lack of control over the conformation of the 
biomolecules, which is critical to their biofunctionality. In our previous studies, we 
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demonstrated that AMPs can be immobilized on titanium implant surfaces through the 
engineering of chimeric peptides that use molecular recognition to attach and self-assemble 
on the implant surface as a novel biomolecular-coatings.27-29 A chimeric peptide is a 
bifunctional single relatively short peptide chain compared to polypeptides and it joins two 
functional domains through an engineered spacer. The functional domain joined to the 
AMP for immobilization on implant surface is a peptide that is identified using 
combinatorial biology based molecular libraries, i.e. phage and cell surface display 
libraries. These genome-based screening process of the peptides allows for finding the 
potential candidates that can interact with the solid materials building upon molecular 
recognition, a feature similar to Nature. Due to phenotype-genotype based relations 
obtained for inorganic materials throughout the combinatorial biology-based selection 
process, these peptides are generally referred as genetically engineered peptide for 
inorganics (GEPIs). GEPIs offer the ability to use molecular recognition to self-assemble 
active peptide-based agents selectively on inorganic materials including titanium 
implants.30,31 Previous work has identified several titanium binding peptides (TiBP) that 
assemble onto the titanium surface with high affinity appropriate for the surface of titanium 
and titanium alloy based implants.28,32 Peptide based self-immobilization strategies 
therefore offer an opportunity to overcome the limitations and challenges associated with 
covalent immobilization of antibacterial agents on implant surfaces. 
The current paper builds upon our studies suggesting that the function of an 
engineered chimeric peptide can be further improved through a spacer region that is placed 
in between the individual functional domains, i.e. TiBP and AMP. This novel design 
employed here allows retention of AMP secondary structural features responsible for the 
antimicrobial activity without jeopardizing the implant self-assembling domain of the 
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peptide. The changes offered in the spacer design induce enough structural alterations in 
the chimeric peptide to be more effectively displayed at the bio-materials interfaces. 
Herein, we demonstrate that engineering the length and composition of the spacer led to 
improved antimicrobial function and favorable host cell response. Chimeric peptides offer 
a simple unifying strategy to immobilize AMPs as a uniform bio-coating on titanium 
implant surfaces to combat implant failure due to infection.  
 
MATERIALS AND METHODS 
Chimeric Peptide Design 
Titanium binding peptide (TiBP) and antimicrobial peptide (AMP) domains 
previously demonstrated as viable in a chimeric peptide (TiBP-Spacer3-AMP) were 
selected for this work.32 Briefly, TiBP was selected by screening a bacterial surface display 
system, FliTrx (Invitrogen, Carlsbad, CA) against a titanium surface.30,31,33 After four 
rounds of biopanning, 60 clones were selected and characterized based on their surface 
binding affinity using fluorescence microscopy techniques. The strongest binding sequence 
determined through these experiments was used in our chimeric peptide to bind to the 
titanium surface, anchoring the chimeric peptide. The AMP domain used in our chimeric 
peptide was computationally designed by data mining the literature.28,34,35 A novel spacer, 
Spacer5 was designed as an elongated link, joining TiBP with AMP to form the chimeric 
peptide, TiBP-Spacer5-AMP. TiBP-Spacer5-AMP was synthesized using solid phase 
peptide synthesis by KanPro (Lawrence, KS). Physical chemical data including, molecular 
weight, isoelectric point, charge and GRand AVerage of hydropathY (GRAVY) scores 
based on amino acid sequences for AMP, TiBP, TiBP-Spacer3-AMP, and TiBP-Spacer5-




Molecular Structure Modeling 
To understand how the secondary structure of the chimeric peptides change in 
solution depending on the spacer sequence, we generated ensembles of 1,000 likely 
structures using the PyRosetta project software and identified secondary structures with the 
DSSP program.37,38 Structure generation is stochastic using a knowledge-based energy 
scoring function. An ensemble of structures was generated for each full chimeric peptide 
and each peptide domain to sample likely structural variations. Ramachandran plots were 
generated for the lowest energy structures for TiBP-Spacer3-AMP and TiBP-Spacer5-
AMP structures. Chimera Software version 1.9 from University of California at San 
Francisco was used to visualize the structures.39 
 
Antimicrobial “Rule Induction” Method 
A “rule induction” method was used to correlate the generated secondary structures 
with the probability of antimicrobial function. Rule induction is a data mining approach to 
learn associations between paired sets of data made of sets of cases. As previously 
published, our paired data is the computationally generated structure decoys for both 
chimeric antimicrobial peptides and antimicrobial peptides paired with the minimum 
inhibitory concentration (MIC) of the peptides in solution.32 Each structural decoy 
represents a single case in a set of cases. Given a list of cases where each case has a list of 
features and a selected outcome, rough-set theory approaches rule induction by looking for 
features which apply to the maximum number of cases and are selective for the selected 
outcome.40 For our project, the cases are structure decoys and the list of features are the 
secondary structure features found. The paired distinct outcome is the MIC result from the 
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in-solution assay. The rough set theory implementation is based on MLEM2.41 Two 
secondary structure features, 4-amino-acid right-handed alpha helices and 5-amino-acid 
alpha helices were key features for rules inducted from our previous work.27 These rules 
associated with strong antimicrobial activity for the bacteria tested (S. epidermidis and S. 
mutans). The secondary structure feature frequencies of these two rules were compared 
against TiBP-Spacer3-AMP and TiBP-Spacer5-AMP. Higher frequencies of these 
secondary structure features associate with stronger antimicrobial activity. 
 
Circular Dichroism (CD) Analysis 
A solution containing 50 μM TiBP-Spacer5-AMP in phosphate buffered saline 
(PBS) at pH 7.4 was prepared for circular dichroism analysis. The spectrum is the average 
of four scans from 190—239 nm using a Jasco J-810 spectrometer (Easton, MD). 
Appropriate background buffer subtraction was performed and the instrument carefully 
calibrated. The averaged spectrum was subtracted from background and smoothed with the 
Savitzky-Golay algorithm. The spectrum was transformed for mean residue ellipticity in 
degrees∙cm2/dmol. Two methods were used to estimate the secondary structure features 
from the CD spectra. The CAPITO method makes a comparison to reference spectra for 
helix (α-helix, 310-helix and π-helix), β-strands (β-sheets, β-bridge) and irregular secondary 
structures (bonded turns, bends and loops) using a liner regression method.42 The Raussens 
method is a concentration-independent estimation of α-helix, β-sheets and irregular 




Bacterial Maintenance and Culturing 
The antimicrobial activity of TiBP-Spacer5-AMP was evaluated against two 
bacterial strains, Streptococcus mutans (American Type Culture Collection (ATCC) 
25175, Manassas, VA) and Staphylococcus epidermidis (ATCC 29886). S. mutans cultures 
were prepared using Brain Heart Infusion Broth (BHI, BD Difco, Franklin Lakes, NJ) and 
S. epidermidis using Nutrient Broth (NB, BD Difco) according to ATCC protocols. 
Bacterial pellets obtained from ATCC were rehydrated in appropriate media of which 
several drops were used to streak either BHI or NB agar plates. Bacteria streaked agar 
plates were subsequently incubated for 24 hours. Agar plates and cultures were incubated 
at 37 oC in the presence of five-percent CO2-supplemented atmosphere for S. mutans and 
in aerobic atmosphere and 200rpm shaking for S. epidermidis. Overnight cultures were 
made by aseptically transferring a single-colony forming unit (CFU) into 10mL of 
appropriate broth media followed by incubation in appropriate conditions for 16 hours. 
Bacteria from overnight cultures were used to inoculate fresh media and grown to mid-log 
phase. 
 
Antimicrobial Activity in Solution 
The minimum inhibitory concentration (MIC) of TiBP-Spacer5-AMP against S. 
mutans and S. epidermidis in solution was evaluated in 96 well plates (Corning Costar 
3370, Corning, NY) spectrophotometrically over a period of 24 hours by obtaining a 
measurement for the optical density at 600 nm (OD600) every two hours. Optical density at 
600nm was measured using a Cytation3 microplate reader (Bio Tek Instruments, Winooski, 
VT). Bacteria grown to mid-log phase at a density of 107 CFU/mL were cultured at 
appropriate growth conditions in appropriate broth media only as a control or in broth 
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media containing a range from 5-70µM of TiBP-Spacer5-AMP for S. mutans and 1-10µM 
for S. epidermidis. The OD600 measurements obtained, relating optical density to bacteria 
CFUs/mL, were plotted versus time to generate standard growth curves. The minimum 
concentration of TiBP-Spacer5-AMP at which no increase in optical density measurement, 
corresponding to no bacterial growth occurring was designated as the MIC. AlamarBlue 
assay (Invitrogen, Carlsbad, CA) was used for determination of a minimum bactericidal 
concentration of TiBP-Spacer5-AMP. Bacteria in broth media only and with the TiBP-
Spacer5-AMP concentrations described in the MIC experiments were prepared in 96 well 
plates. AlamarBlue reagent was added to experimental wells and incubated for two hours 
at 37oC. Experimental wells were observed and evaluated for color change. Wells 
corresponding to concentrations of TiBP-Spacer5-AMP where no color change occurred 
were determined to have bactericidal concentrations of the chimeric peptide.  
 
Titanium Surface Preparation 
Two surfaces, 99% pure titanium foil (Alfa Aesar 43677, Ward Hill, MA) and 
titanium implant discs cut from orthopedic bar material (University of Kansas Medical 
Center Department of Neurosurgery, Kansas City, MO) were used for evaluation of TiBP-
Spacer5-AMP bio-coating antimicrobial activity. Titanium foils were cut into squares 
measuring 0.5 mm thick x1 cm x 1 cm and 6 mm diameter implant rods were cut by the 
University of Kansas Medical Center Department of Neurosurgery with a standard 
orthopedic surgical rod cutter into 3 mm long disc segments. Surfaces were sterilized by 
soaking overnight in 70% bleach, followed by sonication for 15 minutes in each 1:1 
acetone:methanol, isopropanol and filtered deionized water, dried under UV light in a 




Chimeric Peptide Coating on Surfaces 
Sterilized titanium surfaces were transferred to sterile 24 well plates (Costar 3738) 
with the bactericidal concentrations (60µM for S. mutans and 10µM for S. epidermidis) of 
TiBP-Spacer5-AMP dissolved in phosphate buffered saline (PBS) at pH 7.4 and incubated 
at 37oC, constant agitation (200rpm) for 4 hours.27 Following incubation substrates were 
washed twice by pipetting with PBS to remove unbound peptide and transferred to sterile 
24 well plates to be used in experiments.  
 
Antimicrobial Activity on Substrates 
Antimicrobial activity of TiBP-Spacer5-AMP bio-coated titanium surfaces against 
each bacterial strain was evaluated by culturing bacteria in 24 well plates containing bio-
coated surfaces or bare, untreated control surfaces. Bacteria grown to mid-log phase at a 
concentration of 107 CFU/mL were harvested by centrifugation at 2000xg for five minutes 
followed by resuspension in 500µL of appropriate media, transferred to sterile 2 mL 
centrifuge tubes, and then centrifuged at 2000xg for three minutes.27 The supernatant was 
carefully removed from the pellet and the pellet resuspended in PBS at final concentration 
of 108 CFU/mL and 500µL of suspension was added to wells containing foil surfaces and 
1000 µL to wells with implants. Well plates with TiBP-Spacer5-AMP bio-coated surfaces 
were incubated for two hours at 37 oC in the presence of five-percent CO2-supplemented 
atmosphere for S. mutans and in aerobic atmosphere and 200rpm shaking for S. 
epidermidis. Following incubation all surfaces were washed with PBS to remove unbound 
bacteria. Bacteria were fixed with 1 mL of 2% gluteraldehyde solution for 30 minutes and 
then dehydrated in 50, 70, 90 and 100% ethanol baths, 10 minutes for each ethanol 
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concentration. Bacteria were stained with SYTO 9 green fluorescent dye (Life 
Technologies L7012, Carlsbad, CA), incubated for 15 minutes at room temperature 
protected from light and excess dye was removed by washing twice with PBS. Stained 
bacteria were imaged with a fluorescence microscope (Olympus Spin Disk Epifluorescent 
microscope, Richmond Hill, Ontario, Canada) at an excitation/emission wave number 
provided by the manufacturer. Five representative fluorescence images were taken for each 
sample (n=3) and the bacteria were quantified using ImageJ Software and then subjected 
to statistical analysis.  
 
Host Cell Response  
Host cell response was evaluated with a fibroblast cell line (NIH/3T3 ATCC CRL-
1658). The fibroblast cells were cultured following the ATCC protocol. Briefly, cells were 
grown in DMEM media (Gibco 11995073, Carlsbad, CA) supplemented with 10% fetal 
bovine serum (Gibco 10437036) and 1% penicillin-streptomycin (Gibco 15070063) and 
incubated at 37ºC in a five-percent CO2 atmosphere. Fibroblasts were passaged using 
0.25% Trypsin-EDTA (Gibco 25200072) and cells were counted to ensure correct seeding 
concentrations.  
Fibroblast cell response to 60µM TiBP-Spacer5-AMP bio-coating, 200 µg/mL 
collagen (Sigma C7661, St. Louis, MO) coating (positive control) and bare, untreated 
(negative control) titanium foil and implant surfaces was studied. Fibroblast cells at a 
concentration of 8x105 cells/mL were added to sterile 24 well plates containing TiBP-
Spacer5-AMP coated, collagen coated, or bare, untreated foils or implants and incubated 
for 24 hours at 37ºC in a five-percent CO2 atmosphere. Fibroblast attachment and 
spreading were evaluated by fixing fibroblasts on titanium surfaces with 2% gluteraldehyde 
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solution, followed by dehydration in 10, 30, 60, 90 and 100% ethanol. Fixed fibroblasts on 
titanium surfaces were washed twice with PBS, permeabilized with TritonX (Sigma 
T8787), sealed with BSA (Fisher BioReagents BP671-10, Carlsbad, CA), and stained with 
Alexa Fluor488-Phalloidin dye (Invitrogen). Unbound dye was removed by washing with 
PBS and substrates were imaged with a fluorescent microscope at 4, 10, and 20 times 
magnification. Five representative images of each surface (n=3) were obtained and 
analyzed with ImageJ Software and then subjected to statistical analysis. Cell attachment 
was determined as number of cells per square millimeter and the percentage of the image 
surface covered by attached cells. Another measure of viability, metabolic activity was 
determined using a MTT Assay (Sigma M5655). Following incubation of fibroblasts with 
TiBP-Spacer5-AMP, collagen, or bare, untreated titanium surfaces for 24 hours at 37ºC in 
a five-percent CO2 atmosphere, one tenth of the well liquid volume was removed and 
replaced by the same volume of 5 mg/mL MTT reagent. The substrates with MTT reagent 
were incubated for 3 hours then transferred to a sterile 24-well plate. The formazan crystals 
were dissolved in the detergent reagent according to the manufacture’s protocol. 
Absorbance was measured at 570 nm.  
RESULTS AND DISCUSSION 
Here, we engineered and evaluated a chimeric peptide composed of a titanium 
binding and an antimicrobial domain linked by a novel spacer design (TiBP-Spacer5-
AMP). Our objective was to preserve the secondary structural features of both the titanium 
binding peptide and the antimicrobial peptide so as to impart an effective antimicrobial 
activity against two bacteria commonly associated with nosocomial implant infections, S. 
mutans and S. epidermidis.44,45 Data from a similar chimeric peptide with identical 
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functional domains, but a shorter spacer sequence (TiBP-Spacer3-AMP) and the AMP 
peptide alone were used to evaluate the effect of the new engineered spacer design.27-29  
Table 2-1: Physical chemical properties and amino acid sequences for TiBP, AMP, and two chimeric 
peptides TiBP-Spacer3-AMP and TiBP-Spacer5-AMP. Notes: MW, molecular weight; pI, isoelectric point; 
GRAVY, GRand Average Value of hydropathicitY; and \_", gap inserted for sequence alignment. Despite 
chimeric peptide similarity to one another, we observed improved antimicrobial activity with the altered 
amino acid composition of the longer peptide spacer, Spacer5. 
 
 
Table 2-1 contains the sequences and physical chemical properties for each 
chimeric peptide and their functional domains. Despite the physical chemical similarity to 
one another, we observed improved antimicrobial activity with the altered amino acid 
composition designed into the longer linker called Spacer5. The interfacial activity model 
suggests that antimicrobial activity depends on amino acid composition and physical 
chemical properties.46 Interfacial activity is the electrostatic and hydrophobic interactions 
between peptides and the lipid surface of the bacterial cell wall. Literature suggests several 
mechanisms leading to cell death following interaction between the peptide and the lipid 
surface including a compromised bacterial cell wall which initiates a cascade of effects 
including cellular respiration, DNA damage and altered gene expression. Recent 
publications indicate the production of reactive oxygen species (ROS) when AMPs attack 
bacteria.47,48 49 Much of the literature characterize AMP activity based on either structure-
function relationships or physical chemical properties.46 The effect of the engineered 
spacer design was evaluated through independent, but corroborating approaches, 
including: computational and direct structural analysis coupled with measurement of 
antimicrobial activity of the chimeric peptide in solution, as well as when bound to titanium 
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substrates against common nosocomial microorganisms allowing us to suggest that the 
restored antimicrobial activity is due to the preserved structure associated with the Spacer5 
design.  
 
Computational structure and function predictions 
Computational molecular structures were generated using the PyRosetta structural 
ensemble generation method.37 One thousand likely energy minimized structures were 
generated for each chimeric peptide, for each spacer sequence, and for each functional 
domain. The lowest energy structure for each is depicted in Figure 2-1 with TiBP, spacer 
domain, and AMP designated with blue-, black-, and red-shading, respectively. The images 
shown in Figure 2-1 represent likely structures that are modeled in solution. Ramachandran 
plots were generated for the lowest energy chimeric peptide structures and are shown in 
the supporting information for TiBP-Spacer3-AMP and TiBP-Spacer5-AMP. The 
Ramachandran plots simulates the contribution of hydrogen bonding among backbone 
atoms and can be interpreted to correlate the contribution of the alpha helix or beta sheet 





Figure 2-1: Lowest energy structures modeled in solution for (a) TiBP-Spacer3-AMP chimeric peptide; (b) 
TiBP-Spacer5-AMP chimeric peptide; (c) Spacer3 (GGG); (d) Spacer5 (GSGGG); (e) AMP; (f) TiBP. The 
peptide backbone is represented as a ribbon to show secondary structure for peptides with side chains 
represented by full atoms. TiBP domains, spacer domains, and AMP domains are designated with blue-, 
black-, and red-shading, respectively. The. TiBP-Spacer3-AMP (a) has an _-helix feature beginning with 
the AMP domain and preserved through Spacer3, whereas TiBP-Spacer5-AMP (b) has a shorter _-helix 
ends at Spacer5. Both functional domains, AMP (e) and TiBP (f) have _-helix secondary structure, with a 
stronger prominence in the AMP domain. 
Previous published analysis using the “rule induction method” suggest that 
increasing the number of short alpha helices is associated with antimicrobial activity, 
therefore we first examined the structure of the chimeric peptides.27 The computational 
structures in Figure 2-1 show the secondary structure features for the chimeric peptides and 
their component parts. The structure of both TiBP and AMP peptides show features of 
alpha helicity with a stronger helicity prominence in the AMP domain (Figure 2-1, E). 
TiBP-Spacer3-AMP (Figure 2-1, A) has an alpha helix feature beginning within the AMP 
domain and preserved through Spacer3. From the Ramachandran plot we conclude the 
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alpha helix feature is approximately 26 amino acids long and confirm that backbone angles 
consistent with alpha helix features are present though AMP, Spacer3, and almost the entire 
TiBP. All but three amino acids correspond to psi/phi angles (-90⁰, -60⁰) consistent with 
alpha helix. Spacer3 consists of but three glycine amino acid residues; therefore the 
minimal side chain size of glycine in Spacer3 could allow the alpha helix feature to be 
preserved across the spacer domain and into the TiBP, producing longer alpha helices. The 
alpha helix feature in TiBP-Spacer5-AMP is comparatively much shorter. The 
Ramachandran plot for TiBP-Spacer5-AMP shows the psi/phi angles (-90⁰, -60⁰) 
corresponding to alpha helicity are assigned to the AMP domain, while psi/phi angles (-
90⁰, +120⁰) corresponding to beta sheet/random coil secondary structures are observed in 
the rest of the molecule. We interpret these finding to suggest that the Spacer 5 segregates 
the AMP domain from the rest of the chimeric peptide, allowing its antimicrobial activity 
to be preserved.  
Table 2-2: “Rule Induction" method predictions of antimicrobial activity based on secondary structure 
features of four and five amino acid alpha helicity present in computationally generated structures.50 
Increasing antimicrobial activity is associated with increasing percent of helix frequency over either a four 
or five amino acid average. The “rule induction method" predicts that TiBP-Spacer5-AMP possesses a 
secondary structure associated with antimicrobial activity to a greater extent than the secondary structure of 
the TiBP-Spacer3-AMP.
 
The Spacer5 (GSGGG) is composed of four glycine and a single serine amino acid 
residues, and the presence of a polar serine residue could produce a slight “ST staple” 
feature in the spacer region producing a backbone bend that prevents the continuity of the 
alpha helix feature observed in TiBP-Spacer3-AMP. The alpha helix property that most 
accurately predicts antimicrobial activity by the “rule induction method” against S. mutans 
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and S. epidermidis is the number of five amino acid- and four amino acid-right-handed-
helices. The “rule induction method” also predicts antimicrobial function based on the 
percentage of these features present in the energy minimized PyRosetta generated 
structures. The “rule induction method” was used to predict the antimicrobial activity of 
TiBP-Spacer5-AMP and TiBP-Spacer3-AMP with the results shown in Table 2-2. Of the 
one thousand structures generated in the ensembles for each chimeric peptide, TiBP-
Spacer5-AMP had a larger percentage of structural topologies represented with four or five 
amino acid residue alpha helix features. This is consistent with what we observed with the 
detailed structure analysis conducted for the lowest energy structure of each chimeric 
peptide. Based on previously published data validating the “rule induction method”, we 
predict that TiBP-Spacer5-AMP should have greater antimicrobial activity in solution 
against S. mutans and S. epidermidis.27 To further corroborate our analysis, we next turned 
to circular dichroism (CD) analysis which can directly measure secondary structure of 
TiBP-Spacer5-AMP. 
 
Structure determination with CD 
The chimeric peptide was prepared at a concentration of 50µM in phosphate 




Figure 2-2: CD spectrum for TiBP-Spacer5-AMP chimeric peptide at a concentration of 50 μM in PBS, pH 
7.4. The feature designated by the arrow indicates a greater preference for right-circularly polarized light 
absorbance compared to the previously published spectrum for chimeric peptide with Spacer3.29 The 
CAPITO and Raussens methods indicates a predominance of irregular and random coil features in the 
spectrum consistent with what is observed in the computationally generated secondary structure for TiBP-
Spacer5-AMP shown in Figure 2-1(b).42,43 
Two complementary methods, the CAPITO and the Raussens method were used to 
quantify the results obtained from the CD spectra.42,43 We applied both the concentration 
dependent CAPITO method and the concentration independent Raussens method for these 
predictions to corroborate outcomes. Both approaches are regression methods used to 
transform CD spectral data in order to identify corresponding structural information from 
a protein database.  
The CD spectrum for TiBP-Spacer5-AMP is depicted in Figure 2-2 with inset table 
containing results from analysis with the regression methods. The spectrum for the 
chimeric peptide with Spacer5 indicates a greater preference for right-circularly polarized 
light absorbance compared to the previously published spectrum for Spacer3, indicating 
that the predominance of alpha helix secondary structure present in TiBP-Spacer3-AMP is 
not preserved through the newly designed Spacer5.29 The CD structural prediction results 
are consistent with the computationally predicted secondary structure analysis, indicating 
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that a majority of the secondary structure of TiBP-Spacer5-AMP is beta sheet or random 
coil. Moreover, both the CAPITO and Raussens method assigns 86% and 55% secondary 
structure to irregular or random coil features, for TiBP-Spacer5-AMP, respectively. In 
addition to random coil features, the Raussens method assigns 38% of TiBP-Spacer5-AMP 
secondary structure to beta sheet features. The Raussens method also corroborates the 
Ramachandran plot prediction for analysis computationally generated structures. These 
secondary structure features are predicted by the “rule induction method” to also produce 
a greater antimicrobial activity for TiBP-Spacer5-AMP. These structural analyses are 
related only to the in solution secondary structure of the chimeric peptides not their 
structures when bound to titanium surfaces. Currently, a computational model for proteins 
bound to a titanium surface does not exist. While this limits our ability to describe the exact 
structural contributions to antimicrobial activity on the titanium implant surface, we can 
however measure the antimicrobial activity of the chimeric peptides in solution and 
empirically apply those findings to titanium surfaces. 
 
Chimeric Peptide Function 
Antimicrobial Effect in Solution 
Antimicrobial activity in solution was elucidated by determining the minimum 
inhibitory concentration (MIC) of TiBP-Spacer5-AMP required to inhibit growth for two 




Table 2-3: MIC of TiBP-Spacer5-AMP, TiBP-Spacer3-AMP, and AMP alone in solution against S. mutans 
and S. epidermidis. There is a three-fold decrease in TiBPSpacer5-AMP MIC against S. mutans. 
 
Previously published MIC values for TiBP-Spacer3-AMP and AMP alone were 
used for comparison.27 MIC data for AMP, TiBP-Spacer3-AMP, and TiBP-Spacer5-AMP 
are depicted in Table 2-3. The MIC value of TiBP-Spacer5-AMP against S. mutans and S. 
epidermidis are 50µM and 8 µM, respectively. We observed a remarkable three-fold 
improvement of MIC antimicrobial activity for the TiBP-Spacer5-AMP against S. mutans. 
This can be attributed to the increased frequency of secondary structural features 
corresponding to antimicrobial activity as predicted by the “rule induction method”, 
corroborating the importance of secondary structure features in antimicrobial peptide 
design. The design of the spacer offers an opportunity to fine-tune the structural properties 
of the chimeric peptide so as to improve its antimicrobial potential. The use of the Spacer5 
results in a chimeric peptide displaying shorter alpha helix structural features compared to 
Spacer3 and yields improved antimicrobial activity. In contrast however, the antimicrobial 
activity of TiBP-Spacer5-AMP against S. epidermidis appears to be slightly diminished 
compared to TiBP-Spacer3-AMP. We cannot yet account for why TiBP-Spacer5-AMP 
was less effective against S. epidermidis, than S. mutans and we are conducting further 
experiments to investigate this observation. 
The bactericidal concentration for TiBP-Spacer5-AMP against each bacteria was 
also determined using the AlamarBlue assay.51 The bactericidal concentration for TiBP-
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Spacer5-AMP was found to be 60µM for S. mutans and 10µM for S. epidermidis. These 
concentrations are only slightly higher than the observed MIC values indicating that TiBP-
Spacer5-AMP corroborating these complementary methods of killing bacteria. Next, we 
used the bactericidal concentrations determined from the AlamarBlue assay to assess the 
antimicrobial activity of medical implants coated with TiBP-Spacer5-AMP by assessing 
bacterial growth on their surfaces. 
 
Antimicrobial Effect on Surfaces 
TiBP-Spacer5-AMP at 60µM for S. mutans and 10µM for S. epidermidis were 
permitted to self-assemble on selected titanium surfaces and evaluated for their 
antimicrobial activity. Titanium foils were selected for their ease of use, while discs cut 
from stock titanium orthopedic bar material were used to ascertain their effectiveness 
directly on a clinically relevant surface. For both surfaces, infectious organisms common 
to clinical infections, S. mutans and S. epidermids, were used to evaluate the antimicrobial 
activity of the bio-coating. Previous published investigation had established the binding 
characteristics and affinity for the titanium binding peptide as part of a chimeric 
molecule.27 Following incubation, the unbound peptide was removed by repeated washing, 
suggesting the antimicrobial activity observed for either titanium surface was the result of 
the chimeric peptide bound to the surface and presenting an antimicrobial activity. The 
observed effectiveness of TiBP-Spacer5-AMP antimicrobial effect against S. mutans is 




Figure 2-3: Fluorescent microscope images of S. mutans bacteria on 99% pure titanium foils and orthopedic 
implant discs with TiBP-Spacer5-AMP bio-coating and bare, bare untreated controls. (Scale Bar is 100 μm) 




Figure 2-4: Fluorescent microscope images of S. epidermidis bacteria on 99% pure titanium foils and 
orthopedic implant discs with TiBP-Spacer5-AMP bio-coating and bare, bare untreated controls. (Scale Bar 






The images are representative areas, and the percent of the total surface area covered by bound bacteria was 
identified by bacterial staining and quantified by analysis with ImageJ. In all cases, TiBP-Spacer5-AMP 
bio-coating reduced the number of bacteria attached to the surface compared to uncoated control surfaces. 
The fold reduction for the number of bacteria on titanium surfaces with TiBP-Spacer5-AMP bio-coating is 




Table 2-4. There is a 6- to 9-fold reduction for S. mutans, with a 33- to 48-fold 
improvement noted for S. epidermidis on foil or implant surfaces, respectively, due to the 
presence of the TiBP-Spacer5-AMP bio-coating. These data suggest that the TiBP-
Spacer5-AMP bio-coating is an effective strategy to combat infections and consequential 
implant failure by reducing bacterial colonization which ultimately transform to a complex 
biofilm that can resist systemic administration of antibiotics and lead to implant failure.52 
Alternatively, the coating formed by the TiBP-Spacer5-AMP may interfere with bacterial 
attachment by forming a biomimetic surface that is less fouling than the bare titanium or 
titanium alloy surface.35 The increasing frequency of antibiotic resistant bacteria in hospital 
settings contributing to nosocomial infections and the increasing number of patients with 
co-morbidities can both contribute to a diminished ability of the host to resist and clear 
bacteria at surgical sites which lead to implant failure. Whether by antimicrobial activity 
or reduced attachment, the reduction in the number of pathogenic bacterial by the TiBP-
Spacer5-AMP would result in improved patient outcomes. Lastly, we evaluated host cell 





Table 2-4: Fold improvement calculated from fluorescent microscopy image analysis of S. mutans and S. 
epidermidis bacteria on titanium foil and implant surfaces with TiBPSpacer5-AMP bio-coating, compared 
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to bare, uncoated control surfaces. There is in resistance to bacteria as a result of the TiBP-Spacer5-AMP 
bio-coating on foil and implant surfaces. 
 
 
Host Cell Attachment and Viability 
Host cell attachment and viability was evaluated in vitro using a fibroblast cell line 
(NIH/3T3) by measuring cell attachment, morphology/spreading, and viability response to 
TiBP-Spacer5-AMP coated substrates. The results are shown in Figure 2-5 for titanium 
foils and those for orthopedic implants are shown in Figure 2-6. The number of fibroblasts 
that attached to the TiBP-Spacer5-AMP bio-coated foils was not statistically different 
compared to an untreated control surface. However, the cells attached on the chimeric 
peptide bio-coated foil surface did demonstrate greater coverage, suggesting they spread 
more effectively compared to cells grown on untreated control surfaces. As expected, 
collagen-coated surfaces, the gold-standard used as a positive control, did out-perform the 
TiBP-Spacer5-AMP chimeric peptide bio-coating. Interestingly, for studies with 
fibroblasts seeded onto titanium implant surfaces, the chimeric peptide bio-coated surfaces 
showed statistically greater cell attachment and spreading properties than observed for the 
unmodified implant substrates. Additionally, the TiBP-Spacer5-AMP bio-coated implant 
surfaces showed adhesion and spreading results that were statistically comparable to the 
positive collagen controls. These results suggest that bio-coating orthopedic medical 
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implants with TiBP-Spacer5-AMP would result in an improved host cell response at the 
implant-tissue interface. 
The MTT assay was used as a live-dead discrimination assay for fibroblasts grown 
on various surfaces. We found that cell viability on either titanium foils or implant surfaces 
treated with chimeric peptide were similar to values observed for the positive control 
collagen coated surfaces (Figure 2-7), with approximately 50% greater cell viability 




Figure 2-5: Fluorescent images of NIH/3T3 fibroblast attachment on titanium foils : Control (no treatment), 
Collagen (200 μg/mL collagen coating positive control), or TiBP-AMP (60 _M TiBPSpacer5-AMP bio-
coating). Scale bar represents 500 μm for 4X images and 100 μm for 20X  images. TiBP-Spacer5-AMP 
biocoated foils had fewer ¯broblasts attach compared to untreated control, however the ¯broblast surface 




Figure 2-6: Fluorescent images of NIH/3T3 fibroblast attachment on titanium implants : Control (no 
treatment), Collagen (200 μg/mL collagen coating positive control), or TiBP-AMP (60 μM TiBP-Spacer5-
AMP bio-coating). Scale bar represents 500 μm for 4X images and 100 μm for 20X images. TiBP-Spacer5-
AMP bio-coated implants showed greater cell attachment and spreading compared to untreated controls and 





Figure 2-7: NIH/3T3 fibroblast metabolism on titanium foils and implants measured by MTT assay. 
Control (no treatment), collagen (coated with 200 μg/mL collagen), TiBP-AMP (coated with TiBP-
Spacer5-AMP at 60 μM). 
 
CONCLUSION 
A titanium binding, antimicrobial chimeric peptide with novel spacer design (TiBP-
Spacer5-AMP) was rationally engineered. Computational structure analysis revealed 
secondary structural features that were dependent on the length and composition of the 
spacer. These features were confirmed through direct evaluation with circular dichroism 
(CD). Specifically, TiBP-Spacer5-AMP has a multiple short alpha helix features with 
predominately irregular or random coil secondary structure corroborated by Ramachandran 
plot analysis of energy minimized structures and CD. The previously developed “rule 
induction method” was applied and predicted the beneficial effect of structural features 
induced by the spacer that resulted in greater antimicrobial activity. In fact, a three-fold 
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decrease in MIC that indicates increased antimicrobial activity was observed against 
bacteria common to nosocomial implant infection. TiBP-Spacer5-AMP was assembled on 
titanium foils and orthopedic implant surfaces as a biomimetic coating which reduced 
bacterial numbers nine-fold against S. mutans,a bacteria common to dental implant 
infections, and 48-fold against S. epidermidis bacteria common to orthopedic implant 
infections. The potential of the chimeric peptide bio-coating to promote host cell 
attachment was evaluated using a fibroblast cell line. On chimeric peptide bio-coated 
surfaces, the cells attached, spread and exhibited 50% greater viability measured by a 
metabolic assay compared to identical cells on bare, untreated titanium surfaces. Data from 
the TiBP-Spacer5-AMP point to the importance of optimal design of the spacer between 
two functional domains within the chimeric peptide in order to optimize the function of 
each domain, namely binding and self-assembling onto titanium surfaces and the displayed 
antimicrobial activity on the biomaterial surface. The ability to create an antimicrobial bio-
coating on titanium medical implants that serve to overcome complications associated with 
implant failure due to nascent infection and their eventual loss by infection that contributes 







Figure 2-8: Ramachandran Plot of TiBP-Spacer3-AMP generated from the lowest energy computationally 
generated structure. Orange triangles, green squares, and blue circles, designate contributions from TiBP, 
Spacer3, and AMP domains, respectively. Psi/phi angles (-90°,-60°) predicting prominent α-helix structure 




Figure 2-9: Ramachandran Plot of TiBP-Spacer5-AMP generated from the lowest energy computationally 
generated structure. Orange triangles, green squares, and blue circles, designate contributions from TiBP, 
Spacer5, and AMP domains, respectively. Psi/phi angles (-90°, -60°) corresponding to α-helicity are assigned 
to the AMP domain, while psi/phi angles (-90°, +120°) corresponding to β-sheet/random coil secondary 












Table 2-5: Minimum Inhibitory Concentrations of TiBP-Spacer5-AMP evaluated against S. mutans and S. 
epidermidis in solution. Growth was monitored every two hours for 24 h by measuring the optical density 
at 600nm (OD600) corresponding to bacterial CFU/mL. Entries with a “+." indicate bacterial growth did 
occur at that concentration of TiBP-Spacer5-AMP, whereas entries with a “-" indicate inhibition of 






CHAPTER 3 – MITIGATION OF PERI-IMPLANTITIS BY DESIGN AND 




The integration of molecular and cell biology with materials science has led to 
strategies to improve the interface between dental implants with the surrounding soft and 
hard tissues in order to replace missing teeth and restore mastication. More than 3 million 
implants have been placed in the US alone and this number is rising by 500,000/year. Peri-
implantitis, an inflammatory response to oral pathogens growing on the implant surface 
threatens to reduce service life leading to eventual implant failure, and such an outcome 
will have an adverse impact on public health and significant health care costs. Here we 
report a predictive approach to peptide design, which enabled us to engineer a bifunctional 
peptide to combat bacterial colonization and biofilm formation, reducing the adverse host 
inflammatory immune response that destroys the tissue surrounding implants and shortens 
their lifespans. This bifunctional peptide contains a titanium-binding domain that 
recognizes and binds with high affinity to titanium implant surfaces, fused through a rigid 
spacer domain with an antimicrobial domain. By varying the antimicrobial peptide domain, 
we were able to predict the properties of the resulting bifunctional peptides in their entirety 
by analyzing the sequence-structure-function relationship. These bifunctional peptides 
                                               
 
 
1 * Wisdom C, Zhou, Y., Chen, C., Tamerler, C., and Snead, M.L. Mitigation of peri-
implantitis by design and stability of bifunctional peptides with antimicrobial properties. 
ACS Biomaterials Science & Engineering. 2019 
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achieve: 1) nearly 100% surface coverage within minutes, a timeframe suitable for their 
clinical application to existing implants; 2) nearly 100% binding to a titanium surface even 
in the presence of contaminating serum protein; 3) durability to brushing with a 
commercially available electric toothbrush; and 4) retention of antimicrobial activity on 
the implant surface following bacterial challenge. A bifunctional peptide film can be 
applied to both new implants and/or repeatedly applied to previously placed implants to 








There is a continuing need to improve patient treatment to ensure the longevity of 
the therapeutic advantages offered by titanium dental implants 53-60. The creative fusion of 
molecular and cell biology with materials science and engineering has resulted in improved 
understanding of implant-tissue interfaces 61. These advances have been translated 
clinically to improve oral and systemic health through the replacement of diseased teeth by 
titanium dental implants, among numerous examples 35,62,63. Titanium and its alloys have 
the requisite toughness needed to resist the repeated loading that occurs with food 
mastication. Titanium is biocompatible, and more importantly, inherently promotes its own 
integration into host bone by activating the Wnt/integrin signaling pathway for 
osteogenesis 64. 
In recent years, increased reliance on dental implants to restore missing teeth has 
resulted in a concomitant rise in the prevalence of peri-implant disease, a host-mediated 
immune response to bacteria which can shorten implant life and culminate in the loss of 
the implant 65,66. A growing consensus suggests that peri-implant disease is similar to 
periodontal disease: bacterial plaque accumulation and microbiome dysbiogenesis trigger 
a host immune inflammatory response that destroys soft- and hard-peri-implant tissues 67-
69. Within weeks after implant placement, a biofilm develops consisting of the typical 
subgingival bacterial species, including keystone periodontal pathogens such as A. 
actinomycetemcomitans, P. gingivalis, T. forsythia, T. denticola, and P. intermedia 70-72. 
Dysbiosis shifts the relative abundance of commensal species to pathogens. For many 
patients, this shift induces the host to mount an inflammatory response leading to peri-
implant disease, starting with peri-implant mucositis and progressing to peri-implantitis, 
which is accompanied by dramatic bone loss that can necessitate implant removal 73. A 
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treatment protocol that can slow and/or prevent bacterial infection may help to mitigate the 
host immune response and slow peri-implant disease progression. 
The incidence of peri-implantitis is reported to be as high as 14.5% after 9 years of 
service although clinically significant, non-linear loss of bone support around the implants 
may be present as early as after 3 years after placement in more than 80% of patients 74. 
With over 3 million implants placed in the US alone and growing by 500,000 implants/year 
59, a reduced service life ending in implant failure will adversely impact public health, 
trigger increased health care costs and precipitate a loss of public confidence in the dental 
profession. Furthermore, this outcome may dissuade many patients to avoid this therapy 
who would benefit from the health benefits of implants. Currently, the goal of implant 
disease treatment is to control bacterial infection through mechanical debridement and 
bacterial plaque control, in order to mitigate the host immune response, in order to slow 
disease progression 75. However, debridement, which is often performed with titanium 
brushes 76, results in implant surface damage and loss of biocompatibility. This hastens 
inevitable apical movement of the implant-supporting tissues and worsens the loss of 
supporting hard and soft tissue.  
An additional challenge associated with prevention of implant infection is the 
increased incidence of bacterial resistance, which represents a major public health concern 
77-80. Novel antibacterial agents and strategies are needed to ensure future therapeutic 
efficacy 81. While systemic antibiotics can treat infections that result from non-resistant 
bacteria, the peri-implant environment poses many challenges. Implant surfaces are 
susceptible to biofilm development as bacteria attach to the surface and synthesize an 
extracellular biofilm matrix 52. An estimated 80% of human infections are associated with 




difficult for antibiotics to penetrate 52,83. Poor antibiotic penetration into biofilms results in 
subtherapeutic antibiotic concentrations and increases the likelihood of developing 
antibiotic resistance 84. Preventing the attachment of planktonic bacteria to the implant 
surface, while killing them via antimicrobial agents that do not lead to the development of 
resistance represents a novel strategy for reducing biofilm formation and preventing 
persistent infection that leads to implant failure 11,12. One approach to addressing bacterial 
resistance is the use of antimicrobial peptides (AMPs). AMPs are natural antimicrobials 
that form part of the innate immune defense peptides of both invertebrates and vertebrates. 
Most AMPs contain fewer than 50 amino acids and more than 2800 AMPs have been 
discovered from natural resources 80. Integration of computer-assisted peptide design 
methods has increased the number of in silico designed antimicrobial peptides. The 
mechanisms of AMP action on bacteria includes membrane perturbation, disruption and/or 
translocation affecting diverse physiological events such as cell wall biosynthesis, pore 
formation, and cell division, as well as non-membrane-based pathways. The mechanism for 
GL13K action on bacterial membranes involves localized removal of lipid from the 
membrane through peptide induced micellization. The mechanism for action of AMPA 
is not yet fully explored, it is also considered to have its action through membrane 
permeation 85,86. Furthermore, their antimicrobial affects can mitigate biofilm formation 
when used alone or in combination with other AMPs, or even with antibiotics, to achieve 
the desired antimicrobial effect and preserve the health of the host tissues without 
triggering resistance.  
Systemic delivery of AMPs has been a major limiting factor in their wider use as 
therapeutics because a high AMP concentration is required to achieve effective 




87. Local delivery of AMPs may overcome this challenge by reducing and focusing the 
required therapeutic concentration and thereby decrease the potential for deleterious effects 
on eukaryotic cells 87. The advantages of delivering AMPs locally have been explored 
using a variety of methods for their retention on implant surfaces, including physical 
adsorption and chemical immobilization strategies. Chemical immobilization strategies 
include covalently attaching AMPs to the implant surfaces using silane-, catechol- and 
phosphate-groups 88-91. Structural constraints introduced to the AMP during covalent 
coupling are known to limit antimicrobial activity, more so, the covalent coupling 
procedure can only be performed prior to implantation as they are generally performed 
under harsh conditions which prevents their intraoral application. To this point, 
investigators recently demonstrated that amphipathic GL13K antimicrobial peptide can be 
used to coat dentin to resist recurrent caries around resin bonded dental restorations 92,93.  
Combinatorial screening of peptide sequences with affinity for various materials 
has identified hundreds of peptides with the ability to self-assemble on metal-, metal oxide, 
mineral- and polymer-surfaces. As the number of the biocombinatorially selected peptides 
increased, computational methods have provided an understanding for the peptide-solid 
materials interactions, as well as for their self-assembly and molecular recognition 
mechanism(s) on nanostructured materials including metals, metal oxides, ceramics and 
others 94-98. By merging biocombinatorial and computationally methods, we have 
developed high affinity inorganic binding peptides for titanium and titanium alloys. 
Furthermore, we have engineered these peptides into bifunctional peptide molecules that 
incorporate biologically instructive signaling functions in order to create novel, bioactive 
biomaterial interfaces 31,99-102. We demonstrated that titanium binding peptides (TiBP) can 
be used to design a biomimetic interface for enhancing bioactivity in osteoblast and 
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fibroblast cells when coupled with RGD peptides 103. We have further demonstrated that 
TiBP is an effective anchor for AMPs on implant surfaces, serving to localize the molecule 
effectively for repeated intraoral applications 104. When a TiBP anchor was combined with 
a Wnt signaling peptide 105,106, the resulting bifunctional peptide produced a peptide film 
on implant surfaces that led to enhanced osteogenesis in human stem cells, consistent with 
directed bone regenerative capacity 35. We next combined the TiBP with antimicrobial 
peptides and demonstrated their effective use against E. coli, S. epidermis and S. mutant 
strains 29 50. While our earlier studies utilized a simple flexible spacer of amino acids, e.g., 
"GGG", to combine two distinctive AMPs, we have now analyzed sequence-structure-
function relationships for optimal design of the spacer. By computationally studying the 
Dictionary of Protein Secondary Structure (DSSP) features and observed patterns, we 
proposed secondary structure “rules” to enhance antimicrobial activity of bifunctional 
peptides. By designing a rigid and longer amino acid spacer domain, "GSGGG", between 
the TiBP and the AMP domains, we significantly improved the antibacterial efficacy 
against S. mutans bacteria 107. We demonstrated the TiBP as an effective anchor for the 
AMPs on implant surfaces serving to localize the molecule effectively for repeated 
intraoral applications 104. 
Here, we report a novel antimicrobial medicinal approach to slowing or halting the 
progression of peri-implant disease by furthering the design of bifunctional peptides that 
deliver a local antimicrobial peptide. This film can be applied in two minutes and can be 
repeated at follow up appointments.  The renewable effects of the bifunctional peptides 
upon successive reapplication were evaluated on bacteria-fouled and -cleaned dental 
implant surfaces, mimicking the re-treatment of implants affected by peri-implant disease 
in a dental office 104. We systematically studied the sequence-structure-function 
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relationships of two bifunctional peptides that incorporated structurally distinctive 
antimicrobial peptides combined with the same anchoring domain using a newly developed 
longer, more rigid peptide spacer. Our secondary structure prediction suggested that greater 
helical content could improve antimicrobial activity while preserving the intrinsically 
disordered behavior of TiBP for effective surface binding. The resulting bifunctional 
peptides were evaluated for their suitability for clinical deployment using tests of peptide 
binding, stability, antimicrobial function and durability in vitro on titanium implant discs. 
Our computational predictions were merged with experimental structural analyses and 
showed enhanced design of bifunctional peptides with the best candidate molecules 
outperforming other peptides in promoting antimicrobial film activity. Overall, we 
demonstrate that our engineered small bifunctional peptide selectively binds to 
titanium/titanium alloy implant surfaces to deliver an antimicrobial peptide film in as little 
as two minutes. This non-surgical approach has the potential to improve oral health by 
controlling microbial dysbiogenesis and reducing peri-implant disease progression. This 
approach could be more widely beneficial for the design of a range of bioactive 
biomaterials interfaces that could for the basis for next generation therapeutics. 
 
MATERIALS AND METHODS  
Peptide Synthesis, Purification, and FITC-Derivatization 
Peptides were synthesized by standard solid phase peptide synthesis technique 
using Fmoc chemistries and Wang resins (AAPPTec Focus XC solid phase peptide 
synthesizer, Louisville, KY). Fmoc protecting groups were removed by 20% piperidine in 
dimethylformamide (DMF). Following deprotection, piperidine was removed by DMF and 
the samples were solubilized in DMF at a concentration of 0.2M and added in 7-fold 
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excess. The amino acids were activated with 0.4M O-benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU) and 1M 4-methyl morpholine 
(NMM) in DMF. Reactions were performed with mechanical mixing under nitrogen gas. 
Resin-bound peptides were dried with ethanol and cleaved using a cleavage cocktail. 
Reagent K (TFA/thioanisole/phenol/ethanedithiol at a ratio of 87.5:5:5:2.5) was used to 
deprotect side-chain and peptides were precipitated with cold ether. The crude peptides 
were purified using reverse phase-HPLC to greater than 98% purity, lyophilized and stored 
at -20°C. 
Fluorescein 5(6)-isothiocyanate (FITC) was used to fluorescently derivatize 
bifunctional peptides on their free C'-termini for experiments requiring visualization of 
bifunctional peptide molecules bound to the surface of titanium implant discs. 
 
Peptide Property Calculations 
Peptide CD Data Collection and Secondary Structure Prediction  
Secondary structure estimation was accomplished using a Jasco J-810 circular 
dichroism (CD) spectrophotometer. Solutions of 40μM peptide in 100mM Tris-HCL buffer 
with varying volumes of 2,2,2-trifluoroethanol (TFE) were prepared for CD analysis. A 
minimum of 8 scans over wavenumber 190-260nm with a scan rate of 0.5 nm/min were 
collected on a calibrated spectrophotometer and averaged. The background was subtracted, 
and the spectra smoothed using the Savitzky-Golay algorithm. The resulting CD spectra 
were deconvoluted using the BeStSel web server for accurate prediction of protein 
secondary structure and folding 108. 
Predicted secondary structure contents for helical (α, and π-helix), beta (β-bridge, 
bonded turn), and irregular (bend and loop) features were determined using the Chou-
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Fasman algorithm. The Chou-Fasman algorithm was applied for each bifunctional peptide 
after uploading their CD spectra and amino acid sequences using the online server available 
through the CD Analysis and Plotting Tool (CAPITO) 109.  
 
Peptide Structure Analysis  
The de novo 3D structural modeling algorithm, PEP-FOLD 3.5, was implemented 
to generate Protein Data Base (PDB) models for a minimum of five of the best predictions 
for each bifunctional peptide sequences 110,111. PEP-FOLD 3.5 was used to generate 3D-
structural conformations of linear peptides. PEP-FOLD 3.5 generates peptide structures by 
assigning one of 27 structural alphabets where fragments of four amino acid residues 
overlap with three residues. The structural alphabet generalizes the secondary structure by 
assigning geometric descriptors created by the Hidden Markov model as described by 
Maupetit, et. al., 112. 3D models were ultimately generated from the fragments using a 
coarse-grained representation and refined by 30,000 Monte-Carlo steps using the PEP-
FOLD 3.5 online service on an average of 200 simulations executed assuming aqueous 
conditions and neutral pH. Once generated, the models were clustered and sorted using 
sOPEP (Optimized Potential for Efficient Structure Prediction) with non-biased modeling. 
Similarity among the predicted secondary structure models for the bifunctional 
peptides was compared for each of the constituent domains: titanium binding domain 
(TiBP), spacer, and each of two unique antimicrobial domains using the MatchMaker tool. 
The individual constituent domain structures were superimposed on the corresponding 
segments of the bifunctional peptide structure. The Match-Align tool was used with a 5Å 
threshold and the percent identity or degree of relatedness was recorded.  Backbone 
rigidity of the bifunctional peptides was predicted using the DynaMine webserver 
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following their amino acid sequence in FASTA format 113. The server segmented the 
sequence and the fragments were used as the input for the DynaMine predictor for the given 
segment length. The predictions for each segment were reassembled to produce a dynamics 
profile from the amino acid sequence.  
Protein Data Bank files containing the secondary structure models generated by 
PEP-FOLD 3.5 were visualized and further analyzed by the UCSF Chimera program 114. 
The theoretical “footprint” for each bifunctional peptide was calculated using the measure 
tool in Chimera. The footprint was determined by obtaining the distance from the α-carbon 
of amino acid residues to obtain length and width values. These measurements were 
converted to corresponding area and the number of peptide molecules required to saturate 
a 10 mm disc surface area serving as an implant mimic was determined. The number of 
peptides was converted to a molecular mass required to deliver the corresponding surface 
coverage to the titanium implant disc surface.  
A web interface program DichroCalc 115 was used to predict the theoretical circular 
dichroism spectra from secondary structures models predicted with PEP-FOLD 3.5. 
Spectra were requested in ellipticity units [(deg cm2)/dmol] over wavenumber 190nm to 
260nm and compared to the corresponding experimentally collected spectra. The Hirst ab 
initio parameter set was used for backbone chromophores.  
 
Titanium Implant Disc Preparation 
Coin-shaped titanium implant discs were punched from grade 4 titanium by the 
USC Engineering Shop. The discs were 10mm in diameter and 0.5mm thick, lap-polished 
and air-blasted with 180-220 micron titanium dioxide particles. Following manufacturing, 
the discs were cleaned as stated in a published protocol used for producing surfaces optimal 
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for osseous integration 56. The protocol included sonication in DI H2O for 5 minutes, 
ethanol for 30 seconds, DI H2O for 30 seconds, 40% sodium hydroxide for 10 minutes, 
washed in DI H2O for 5 minutes, 50% nitric acid for 10 minutes followed by rinsing with 
DI H2O for 5 minutes. The discs were autoclaved prior to use. 
 
Peptide Binding to Implant Discs 
Titanium implant disc functionalization with bifunctional peptides was 
accomplished by incubating 100μL of a specified fold concentration of the theoretical 
“footprint” concentration ontoclean, sterile discs for different time periods at 37°C for 2 
minutes. Following incubation, the discs were transferred to a sterile well in a 24-well plate 
containing 500μL of DI H2O and washed multiple times to remove unbound peptide. The 
discs were transferred to a clean glass microscope slide for imaging using a fluorescent 
microscope. All experiments were repeated a minimum of three times and images were 
recorded at 10X magnification. 
 
Determination of Surface Coverage  
A custom MatLab script was developed to determine the percent surface coverage 
of fluorescently labeled bifunctional peptides on the implant disc surface. The color 
fluorescent images were read into MatLab using the imread function. The images were 
converted to black and white and the total number of black and white pixels quantitated. 
The number of white pixels corresponding to the fluorescently labeled peptides, was 
divided by the total number of pixels to determine the percent surface coverage. The 




an optimal bifunctional peptide interface in a clinically relevant time interval and did not 
include lateral resolution. 
 
Serum Competition Assay 
Serum competition binding assay was completed with 1.0wt%, and 5.0wt% of 
bovine serum albumin (BSA) at selected theoretical “footprint” concentrations of FITC-
labeled bifunctional peptide. Prior to functionalization of sterile titanium implant discs, a 
solution of BSA and the bifunctional peptide was made in a sterile centrifuge tube. In a 
sterile 24 well plate, 100μL of the BSA/bifunctional peptide solution was pipetted onto a 
titanium implant disc and incubated at 37°C for 2 minutes. The discs with 
BSA/bifunctional peptide were transferred to a new well containing 500μL sterile 
deionized water for 1 minute and washed to remove unbound peptide. The discs were 
transferred onto a clean glass microscope slide and imaged as previously described 104.  
 
Mechanical Durability Assay 
 Sterile titanium implant discs were functionalized with FITC-labeled 
bifunctional peptides and brushed using a commercially available electric toothbrush, as 
previously described 63, 78-79. Deionized water was applied to the functionalized discs 
and an electric toothbrush with a round head the same size as the implant disc was applied 
to the disc for 1 minute. A 100g weight was secured to the toothbrush 10cm from the brush 







Streptococcus mutans bacteria (ATCC 700610) were cultured according to an 
ATCC protocol. Frozen stocks were streak plated on agar and incubated for 24 hours at 
37°C in atmosphere with 5% CO2. A single bacterial colony was used to inoculate 5mL of 
Brain Heart Infusion (BHI) broth in a sterile 50mL conical tube and incubated overnight 
in the same conditions. Following incubation, 1mL of culture was added to 9mL of fresh 
media and grown to mid-log phase with a final concentration of 105 CFU/mL. 
 
Visualizing Bacteria on Implant Discs 
Following the functionalization of titanium discs, they were transferred to a sterile 
well in a 24-well plate and 400 μL of S. mutans bacteria at a concentration of 103 CFU/mL 
was added to the wells containing the discs and incubated for 24 hours at 37°C in 
atmosphere with 5% CO2. Following incubation, discs were imaged with a fluorescent 
microscope to visualize FTIC-labeled bifunctional peptides on the disc surface after 
bacterial challenge. The dead bacteria were stained with propidium iodide and imaged 
using a fluorescent microscope. Experiments were repeated in triplicate and images were 
recorded at 10X magnification. 
 
Statistical Analysis 
For all experimental groups, values are reported as mean ± standard deviations. 
One-way analysis of variance (ANOVA) was performed to assess statistical significance. 





RESULTS AND DISCUSSION 
We explored the structure-function relationship of bifunctional peptides designed 
with two distinct antimicrobial peptide domains. Each bifunctional peptide molecule 
incorporated three peptide domains: an implant anchoring domain provided by the TiBP, 
an antimicrobial domain provided by the AMP, and a spacer domain to ensure the 
functionality of each of the two other domains when constrained within a single peptide 
chain. Computationally derived rules for predicting performance of antimicrobial 
bifunctional peptide films and experimentally evaluated for antimicrobial activity, extent 
of film coverage and binding, binding under competition from an interloper contaminant, 
and mechanical durability within clinically relevant parameters needed by dentists to treat 
peri-implant disease.  
Schematic 1: Our approach includes an antimicrobial peptide film based upon an engineered 
bifunctional peptide composed of peptide domains for implant binding and antimicrobial activity separated 
by a spacer. The peptide was tested using a variety of in vitro assays to demonstrate its suitability. 
 
Design by Structure Prediction from Amino Acid Sequence 
In our earlier work, we identified secondary structure rules that associate greater 
antimicrobial property with a-helix features adopted over 4- and 5-amino acid residues 50. 
Based on this, we screened the CAPITO webserver provided in the Antimicrobial Peptide 
Database (APD) that contains the cationic AMPs identified with low minimum inhibitory 
concentrations (MIC) based on their percentage of a-helix secondary structure 109. The 
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method implemented in CAPITO uses the Chou-Fasman algorithm to analyze the relative 
frequencies of amino acids adopting a specific secondary structure conformation based on 
protein structures previously solved by X-ray crystallography. The secondary structure 
prediction mainly relies on the probability parameters obtained for the occurrence of a-
helix, b-sheet and turns. The Chou-Fasman method is roughly 60% accurate in predicting 
secondary structures compared to 80% accuracy achieved by some of the recent machine 
learning approaches 116; however computationally Chou-Fasman remains a simple and 
efficient method for approximating secondary structure content starting from an amino acid 
sequence. Chou-Fasman was used as an initial estimation tool in developing rules for the 
antimicrobial peptide film property. We identified two AMPs with low MIC: AMPA117, 
comprised of 60% predicted a-helix forming amino acids and GL13K118 containing no 
predicted a-helix forming amino acids (Table 3-1). The MIC for each AMP is given in 
Supplemental Information Table 3-4. 
 
Titanium binding peptides were selected using phage display and characterized for 
their binding affinity using Quartz Crystal Microbalance Spectroscopy (QCM) 50,103. Based 
upon this earlier work, we selected one of the strong titanium binding peptides as a 
promising candidate for the bifunctional peptide film 103. When AMPA was combined with 
a spacer to the titanium binding peptide (TiBP) domain, the a-helix content of the resulting 
bifunctional TiBP-AMPA increased to 69%. Whereas combining TiBP with GL13K 
resulted in a drastic change to the a-helix content for the bifunctional TiBP-GL13K 
molecule, with a-helix content as low as 50%.  
Native chimeric proteins containing multiple functional domains often are 
separated by inter-domain sequences called "spacers" that enable multiple domains to 
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coexist on a single polypeptide chain. Inspired by this, we studied different spacer 
sequences when designing the bifunctional peptides described here. The goal of the spacer 
design was to preserve and enhance the function of each of the functional domains within 
the molecule. We previously tested the effects of spacers on the overall bifunctional peptide 
by testing them with a single antimicrobial peptide, AMP1, linked with a strong titanium 
binding peptide sequence (TiBP) 29,50,103,119. Here, a five-amino-acid spacer, GSGGG, 
resulted in drastic improvement of the antimicrobial efficacy against S. mutans, compared 
to a three amino acid, GGG spacer 120. We therefore elected to combine the TiBP domain 
to each of the two selected AMPs using the GSGGG spacer.  
 
Table 3-1: Chou-Fasman secondary structure predictions from amino acid sequences for the bifunctional 
peptide and its constitutive domains. Secondary structure features including helix (α, 310 and π-helix), beta 
(β-bridge, bonded turn), and irregular (bend and loop) features. 
 
 
Table 3-2 provides the physicochemical properties for AMPs and the related 
bifunctional peptide. Both of the AMPs selected are cationic with net positive charge of 5 
and 4, respectively for AMPA and GL13K. In contrast, the net charges of the corresponding 
bifunctional peptides, TiBP-AMPA and TiBP-GL13K increased to 8 and 7, respectively. 
Table 3-2: Physicochemical properties of peptides . 
⍺-helix β-strand irregular
TiBP 0% 0% 100%
AMPA 60% 0% 40%
GL13K 0% 0% 100%
TiBP-AMPA 69% 0% 31%





The Chou-Fasman secondary structure algorithm predicted greater helical content 
in the bifunctional peptides compared to either of the AMP domains in isolation. Further, 
the distribution of secondary structure between the AMPs in isolation compared to the 
bifunctional peptides suggested that the AMPA domain retained a greater percentage of 
secondary structure than GL13K. Thus, we predicted that a design with AMPA would have 
greater antimicrobial potential than one containing GL13K. We recognize the limitations 
of Chou-Fasman in predicting secondary structure; however, the GL13K a-helix prediction 
differed only by 10% from a recently reported estimate on the secondary structure of 
GL13K using a complementary approach 92,93.  
 
Design by Hydrophobicity and Amphipathicity 
Hydrophobicity and amphipathicity are believed to allow the AMP to penetrate a 
bacterial lipid bilayer and disrupt the cell membrane 121,122. Using the Calculate and Predict 
tool from the Antimicrobial Peptide Database (APD), it was determined that TiBP-AMPA 
has a hydrophobic ratio of 30% with 10 hydrophobic residues aligned along the same 
surface of the a-helix. TiBP-GL13K revealed a hydrophobic ratio of 26%, slightly less 
than that of TiBP-AMPA, with only 5 hydrophobic residues aligned on the same surface 
(Supplementary Information Figure 3-8). This sequence analysis revealed that the majority 
of the hydrophobic amino acids in both bifunctional peptides were located in the AMP 
# AA MW pI Charge GRAVY
TiBP RPRENRGRERGL 12 1496 12 +3 -2.6
AMPA KWKLWKKIEKWGQGIGAVLKWLTTW 25 3085 10 +5 -0.4
GL13K GKIIKLKASLKLL 13 1429 11 +4 0.7
TiBP-AMPA RPRENRGRERGLGSGGGKWKLWKKIEKWGQGIGAVLKWLTTW 43 4991 12 +8 -1
TiBP-GL13K RPRENRGRERGLGSGGGGKIIKLKASLKLL 30 3218 12 +7 -0.8
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region. The TiBP region contains only one hydrophobic residue on the C'-terminus of the 
binding peptide, immediately before the spacer. The hydrophobic nature of the bifunctional 
peptide is attributed to the AMP portion, which may increase the likelihood of the AMP 
interacting with the bacterial membrane while the binding domain remains anchored on the 
implant surface. To visually demonstrate this distribution of residues, we generated helical 
wheels using an online tool (http://rzlab.ucr.edu/scripts/wheel/wheel.cgi). The helical 
wheel diagrams represented in Figure 3-1 show that 10 hydrophobic residues reside on the 
same surface of the a-helix for TiBP-AMPA compared to only 5 for TiBP-GL13K.  
 
 
Figure 3-1: Helical wheel predictions of bifunctional peptides. Hydrophilic amino acid residues are 
represented as circles, hydrophobic amino acid residues as diamonds, potentially negatively charged 
residues as triangles, and potentially positively charged residues as pentagons. The most hydrophobic 
amino acid residue is shown in green with the chroma intensity decreasing proportionally to 
hydrophobicity, with zero hydrophobicity coded as yellow. Hydrophilic residues are coded red with intense 
red chroma being the most hydrophilic (uncharged) residue, and the chroma decreasing proportionally to 




Dynamics Prediction in Bifunctional Peptide Design 
Next, the dynamics of the peptide backbone were studied to determine the disorder 
of the regions within the whole bifunctional peptide relative to their constitutive binding, 
spacer, and AMP domains. DynaMine, a tool that leverages chemical shift data to make 
predictions about backbone dynamics at the amino acid residue level, was used for this 
purpose. The dynamics of the residues are essential for peptide function, so evaluating the 
backbone dynamics in relation to the bifunctional peptide function is important in 
considering the design of these peptides 123. Given a protein sequence, DynaMine predicts 
backbone flexibility at the level of amino acid residue in the form of backbone N-H S2 
order parameter values. These S2 values represent how restricted the movement of the 
atomic bond vector is with respect to the molecular reference frame. The results from the 
DynaMine analysis are depicted in Figure 3-2.  
 
 
Figure 3-2: DynaMine classification for backbone dynamics of amino acids comprising each bifunctional 
peptide. The AMP domains located on the C'-terminus represent a more ordered region relative to the TiBP 
binding domain located on the N'-terminus. The TiBP domain is an intrinsically disordered peptide. AMPA 
has more order than GL13K, which could contribute to its greater predicted antimicrobial function.  
 
The more hydrophilic amino acids located in the AMP domain of the bifunctional 
peptide correspond to the more ordered region of the bifunctional peptide. The Gly and Ser 
residues comprising the spacer region, are known to be more disordered, serving to 
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promote the propensity for a more dynamic backbone that improves overall function of the 
tethered molecule, namely binding to the implant surface while presenting an active 
antimicrobial domain. This is important for dental implants as the accumulation of a 
biofilm on the implant is believed to lead to an adverse host immune response to the 
bacterial antigens, resulting in host directed inflammatory destruction of soft and hard 
tissues surrounding the implant 69,73,124,125. Consistent with this interpretation, the binding 
domain for the bifunctional peptides showed the least variation in order. Intrinsically 
disordered proteins (IDPs) function in a wide spectrum of biological situations due to their 
ability to adapt their structure by adopting conformation over a small number of amino acid 
residues 113,126-128. Thus, it would be expected that the dynamics of the binding domain may 
resemble the range of conformational structure observed within IDPs.  
 
Secondary Structure Modeling and Analysis 
A more in depth secondary structure prediction was accomplished by developing 
structural models from the amino acid sequences using PEP-FOLD 3.5 129. Secondary 
structure models generated for the individual domains and the bifunctional peptide appear 
in Figure 3-3. Secondary structural analysis of the antimicrobial peptide domains, AMPA 
and GL13K, revealed that the AMPA domain is composed of two short a-helixes joined 
by a turn while GL13K is composed of one short a-helix. The Chou-Fasman analysis did 
not identify helicity exclusive to the GL13K domain, although helicity was predicted for 
the bifunctional peptide, TiBP-GL13K.  
The mechanism by which amphipathic a-helical AMPs kill bacteria may involve 
their creation of trans-bilayer pores which serve to disrupt the bacterial membrane by 
separating the polar from the non-polar parts130. Thus, we predicted TiBP-AMPA would 
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have greater antimicrobial activity than TiBP-GL13K due to the greater number of 
membrane-disrupting helical features present in AMPA (two features) compared to GL13K 
(one feature).  
 
 
Figure 3-3: Secondary structure models and structural similarity analysis . Each TiBP domain is colored 
purple, the AMPA domain is colored orange and the GL13K domain is colored red, while the spacer 
domain linking the antimicrobial and binding domains is colored black. The chart depicts the structural 
similarity determined by superimposing the domain models over the bifunctional models and calculating 
the percent identity.  
 
Using Chimera, the PDB file could be compared using the MatchMaker tool and 
the structure models superimposed 39. Similarity among the individual functional domains 
was evaluated by superimposing the structural model for the AMP and TiBP domain alone 
on the corresponding portion of the bifunctional peptide. The superimposed structures were 
further studied to determine the percent identity or the degree of relatedness. This was 
TiBP AMPA GL13K
TiBP-AMPA TiBP-GL13K
Analysis of Structure Similarity








useful in determining the preservation of the TiBP domain and each antimicrobial domain 
when linked by the spacer in the whole bifunctional peptide. This analysis revealed that 
91.7% of the TiBP domain identity was preserved when combined with either AMPA or 
GL13K through the GSGGG spacer. The GL13K domain retained 92.3% identity, while 
the AMPA domain retained only 60% identity. This suggests that most of the secondary 
structure of the TiBP and GL13K domain are preserved by the GSGGG spacer, while 
further engineering of the spacer could improve the antimicrobial activity of TiBP-AMPA. 
Preservation of the TiBP domain is postulated to be critical for binding to the implant 
surface in the presence of competing proteins while contributing to the durability of the 
bifunctional peptide in the oral environment both of which are an essential property for 
effective clinical deployment.  
 
Experimental Determination of Secondary Structure 
Next, secondary structures of the bifunctional peptide were experimentally 
determined using CD spectroscopy in an aqueous environment with increasing 
concentrations of TFE to mimic peptide film behavior. Theoretical spectra were 
determined using DichroCalc from the PDB files generated from the secondary structure 
models. Secondary structures of the bifunctional peptides were evaluated experimentally 
using CD spectroscopy in an aqueous environment. The presence of ordered or disordered 
conformational state was assayed for each bifunctional peptide. We next evaluated the 
folding propensity of the peptide sequences in the presence of increasing TFE 
concentration. TFE is used as a structure stabilizing solvent to mimic the restricted mobility 
of the peptides due to inherited function of the bifunctional peptide. As the bifunctional 
peptide interacts with the titanium surface through its anchoring domain it also interacts 
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with the bacterial membrane via the antimicrobial domain. Theoretical spectra were 
determined using DichroCalc from the PDB files generated from the secondary structure 
models 90. Analysis performed by the Dynamine program for dynamic behavior of the TiBP 
domain suggest the TiBP behaves as an intrinsically disordered peptide. While these 
structural states are representatives of the peptide in aqueous environments, circular 
dichroism data supported this behavior. In the absence of the TFE, both of the peptides 
exhibited a strong negative ellipticity band around 198nm representing the pi-pi* 
transition. This is a characteristic band for random coil conformation which is in 
equilibrium with other secondary structures. Based upon our prior TiBP related work, we 
conclude that the titanium binding features of the bifunctional peptide was preserved. 
Overall, addition of TFE to each peptide resulted in reduced intensity of the pi-pi* 
transition ellipticity band and an observed ~10nm red shift in absorption wavelength. These 
results suggest a shift in secondary structure population and both peptides undergoing some 
degree of conformational reordering in the presence of TFE. Relating such transitions to 
the bifunctionality of the peptide may provide insights for rational design for bioactive 





Figure 3-4: Theoretical and experimental CD spectra with deconvolution using Beta Sheet Selection 
(BeStSel). Experimental CD spectra were collected in aqueous environment and increasing concentrations 
of 2,2,2-trifluoroethanol. The pie charts represent BeStSel’s deconvolution of the CD spectra.  
 
The CD spectra were deconvoluted using Beta Sheet Selection (BeStSel), a method 
for secondary structure determination from CD spectra 108. BeStSel links the CD spectra 
structural findings to the computational Dictionary of Protein Secondary Structure (DSSP) 
patterns 131. Our previously described “Rule Induction” method also relied on DSSP 
structure patterns and identified a pattern of 4- and 5- amino acid a-helix structures as 
being linked to antimicrobial activity in bifunctional peptides 50,120. The BeStSel tool 
allows for deconvolution of experimental CD spectra into the structural feature patterns 
that are used to inform the “Rule Induction” method. Both bifunctional peptides were found 
to switch their conformation from an unordered state in aqueous buffers to their 
functionally relevant a-helical conformation in the presence of TFE. The theoretical CD 
63 
 
spectra determined from the PDB model files more closely represented the 90% TFE 
environment. This suggests that the computational structural predictions are more accurate 
for environments similar to the conditions in which the peptides act as a film. The results 
from the deconvolution using BeStSel for TiBP-AMPA and TiBP-GL13K are depicted in 
Figure 3-4. 
 
Theoretical Surface Coverage Determination 
The concentration of bifunctional peptides theoretical needed to provide 100% 
surface coverage when applied onto an implant-mimicking titanium disc surface was 
estimated by measuring the dimensions of the binding peptide domain to obtain a 
theoretical “footprint” area. The resulting area was used to determine the concentration of 
peptide molecules required to cover a 10 mm diameter titanium implant disc ( 
 
 
Table 3-3). One limitation of the theoretical surface coverage concentration 
calculation is that the surface is assumed to be smooth; however, the surface roughness 
produced by blasting an implant with titanium dioxide to promote osseous integration 
would result in a greater surface area than what would be calculated. This limitation was 
overcome by using a multiple of the theoretical binding concentration, up to 6-times (6X), 
to achieve near 100% surface coverage after a two-minutes binding period. We focused on 
minimizing the time required to achieve complete surface functionalization by the 
bifunctional peptide because this will be important in translating this technology to a 
clinical application. The two-minute binding time frame represents a reasonable working 





Table 3-3: Theoretical “footprint” calculation and concentrations . 
 
 
Evaluation of Binding, Stability and Durability 
The theoretical footprint concentration of each bifunctional peptide with a multiple 
of the binding concentration up to 6X was determined to result in near 100% surface 
coverage after incubation with a titanium implant disc for only two minutes at 37°C. 
Following incubation, the discs were washed to remove unbound or non-specifically bound 
peptide from the surface prior to imaging with a fluorescent microscope. The fluorescent 
images were then analyzed using a MATLAB script to determine the percentage of the 
implant disc covered by the bifunctional peptides. The initial binding for TiBP-AMPA 
resulted in 99% surface coverage after two minutes compared to 96% for TiBP-GL13K. 
This indicates that in a clinically achievable application, the bifunctional peptides are able 
to form an antibacterial film with near complete coverage of the implant surface. 
Representative fluorescent images for each bifunctional peptide are depicted in Figure 3-5, 
while the chart indicates the mean with standard deviation error bars for three replicate 
experiments. 
The bifunctional peptide film could be applied to a new dental implant prior to 
implantation and subsequently during recall appointments for treatment to previously 
placed implants. Recently we demonstrated in vitro, a bifunctional peptide that retained 
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ability to bind to the implant surface after overnight incubation in vitro after bacterial 
fouling and cleaning using a commercially available electric toothbrush 120. The re-binding 
of the bifunctional peptide to a fouled and cleaned surface represents the feasibility of 
applying this technology to existing implants at recall appointments where the bifunctional 
peptide can be reapplied. However, when rebinding the bifunctional peptide in the oral 
environment, the peptide will compete for the implant surface with serum and saliva 
proteins, even after the implant is cleaned using standard dental practices. Thus, the ability 
of the peptide film to functionalize the implant surface in the presence of serum proteins 
was determined by pre-mixing the peptide with varying concentrations of bovine serum 
albumin (BSA) followed by incubating the mixture on the titanium disc for 2 minutes at 
37°C. The results of the competitive binding of the bifunctional peptide in the presence of 
0.01% BSA are depicted in Figure 3-5. TiBP-AMPA achieved 80% surface coverage while 
TiBP-GL13K achieved 73% surface coverage. There was no statistical difference between 





Figure 3-5: Fluorescent microscopy images of binding of bifunctional peptide to titanium implant discs, 
binding with competition from BSA, and durability following 1 minute of brushing with an electric 
toothbrush. The chart depicts the means and standard deviations of three replicate experiments for each 
bifunctional peptide in each condition. TiBP-AMPA binding was statistically significant compared to 
binding in competition with BSA and durability after 1-minute of brushing (p < 0.05). Statistical 
significance was determined for all conditions of TiBP-GL13K bifunctional peptide (p < 0.05). Statistical 




The durability of the bifunctional peptide films was evaluated by brushing the 
functionalized implant discs with a commercially available electric toothbrush with a round 
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head slightly larger than the implant disc for one minute. The presence of bifunctional 
peptides was determined by fluorescently imaging the discs with FITC-labeled peptides 
before and after brushing. The durability of the TiBP-AMPA peptide film was significantly 
(p < 0.05) greater than that of the TiBP-GL13K peptide film. For TiBP-AMPA, 75% of the 
bifunctional peptide coating was retained compared to 27% for TiBP-GL13K (Figure 3-5).  
 
Bifunctional Activities of the Designed Peptides 
The binding and antimicrobial domain activities were evaluated by challenging the 
bifunctional peptide film applied to titanium implant discs with S. mutans bacteria for 24 
hours. The FITC-labeled bifunctional peptides were visualized on the disc surface 
following 24 hours of bacterial challenge using a fluorescent microscope and the surface 
coverage was determined using MATLAB. The surface coverage was 84% for TiBP-
AMPA and 60% for TiBP-GL13K. Representative fluorescent images of FITC-labeled 
bifunctional peptide on the implant disc and quantification of the percent surface coverage 





Figure 3-6: Visualization of FITC labeled bifunctional peptides using fluorescence microscopy after 
challenge by S. mutans for 24 hours. The percentage of peptide coverage was determined by evaluating 
images with a MATLAB script. The chart represents results obtained during three replicate experiments, of 
which, the fluorescence images are selected as representative of the whole. A statistically significant 
difference (p < 0.05) was found between the means for TiBP-AMPA and TiBP-GL13K coverage using a 
one-way ANOVA.  
 
The percentage of a-helical secondary structure computationally predicted by the 
Chou-Fasman method, the secondary structure modeling and the experimental 
determination of secondary structure using CD supported our design prediction that TiBP-
AMPA would outperform TiBP-GL13K in promotion of an antibacterial implant interface. 
We relied upon the previously established “rule” method 132 for the design of the 
bifunctional peptides in this manuscript took into the structural composition of the entire 
bifunctional peptide, not just the binding- or antimicrobial-domains. The rule method was 
trained on antimicrobial function with experimentally determined antimicrobial functions 
to identify secondary structural features in bifunctional peptides that promote formation of 
an effective interface for the prevention of implant associated infection.  
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The antimicrobial functional efficacy of TiBP-AMPA compared to TiBP-GL13K 
supported our design prediction. The use of propidium iodide (PI) staining to identify dead 
bacteria on the titanium disc surface showed 46% dead bacteria coverage for TiBP-AMPA, 
compared to 10% dead bacteria coverage for TiBP-GL13K. Sterilized bare discs were used 
as controls showed no dead bacteria. Representative fluorescent images and quantification 
of three replicate experiments are depicted in Figure 3-7.  
 
 
Figure 3-7: Fluorescence microscopy images and quantification of propidium iodide (PI) staining of dead S. 
mutans bacteria on implant discs after challenge for 24 hours. Dead bacteria appear with red fluorescence. 
The means and standard deviations are depicted in the chart for bare, sterilized titanium discs and discs 
functionalized by 2 minutes of bifunctional peptide binding at 37°C prior to bacterial challenge. Three 
replicate experiments were performed and a statistically significant difference (p < 0.05) was observed 




While one might postulate that this increase in antimicrobial function could due to 
the amount of bifunctional peptide remaining on the surface, e.g. 84% for TiBP-AMPA 
compared to 60% for TiBP-GL13K, the conservation of structure in the TiBP domain by 
the superimposed predicted secondary structures shown in Figure 3-3 suggests equal 
percentages of identity or relatedness for the binding domains. However, the analysis of 
backbone dynamics revealed that the antimicrobial domain of TiBP-AMPA was more 
highly ordered than that of TiBP-GL13K. The expected disordered region represented by 
the TiBP in both bifunctional peptides extends through the spacer, and much of the 
antimicrobial domain is disordered for TiBP-GL13K. This finding could affect the 
anchoring of the bifunctional peptide on the disc, as the disordered region of GL13K may 
be more available to interact with the implant surface nonspecifically. Additionally, the 
proposed mechanism of antimicrobial function is more dependent on the hydrophobicity 
and amphipathicity of the peptide without the additional effects attributed to the increased 
stability and greater number of a-helical secondary structure features in the AMPA 
compared to Gl13K. Secondary structure modeling revealed that the AMPA domain 
comprised two a-helical features joined by a turn compared to only one a-helical feature 
for GL13K.  
The hydrophobic ratio of TiBP-AMPA was slightly greater (30%) than that of 
TiBP-GL13K (26%). More hydrophobic residues were aligned on the same face of TiBP-
AMPA, with 10 residues being aligned for TiBP-AMPA compared to only 5 residues for 
TiBP-GL13K. With regard to hydrophobicity and amphipathicity, the design prediction 
based on the sequence and structure supported the experimental finding that TiBP-AMPA 





Overall, the antimicrobial peptide film property is observed to be dependent on the 
extent of the a-helical secondary structural features. Peptide stability under competitive 
binding environment was observed to be related to the ordered structures observed from 
our analysis of backbone dynamics. Molecular recognition-based peptide self-assembly 
domain prevented removal of the peptide even under harsh washing conditions. Ordering 
seems to provide the TiBP-AMPA peptide a competitive advantage. It may be plausible to 
design TiBP-GL13K with a different spacer combination which would induce an ordering 
in the structure and enhance its competitive binding. Conformational design parameters 
are postulated to play a critical role in the peptide stability considering the anchoring 
domain of the bifunctional peptides are the same. Secondary structure may undergo major 
changes on the metal surfaces, however functional assembly behavior under the 
biologically challenged material interfaces may still have a folding preferential. 
Taken together, our experimental results demonstrate that using computationally 
efficient, less resource intensive methods can be used to successfully predict the properties 
of bifunctional peptide prior to more costly and time-consuming experimental evaluation. 
The computational design approach was validated experimentally by assessing the binding 
and antimicrobial function of bifunctional peptides on a simulated implant surface. This 
technology and approach to design represents a novel strategy to improving and developing 
bifunctional peptide films to combat bacterial infection and prevent/treat peri-implant 
disease. Prior to clinical trials, the cytocompatibility and biocompatibility of the 
bifunctional peptides to human cells will need to be examined. Additionally, the 
incorporation of AMP sequences not previously explored as antimicrobial agents in 
bifunctional peptides represents an opportunity to develop more broad-spectrum 




strains. The predictive design approach developed here offers a method for evaluating the 
functional efficacy of AMP, spacer, and binding domain combinations based on analyses 
of the relationship between sequence, structure and function. Combining this approach with 
the recently developed soft epitaxial fit for the binding domain of the peptide to match 
the epitaxial sites on the implant surfaces would be another area to explore in order to 
tune the functionality at the solid-interface. This approach may also provide predictable-, 
rational-, peptide design approaches for a wide range of hybrid interfaces by combining 
conformational and interface design aspects 
 
CONCLUSION 
We developed a predictive computational approach for designing bifunctional 
peptides that sought to correlate structure and function, e.g. antimicrobial activity and 
demonstrated that the resulting peptides show promise as a medicinal approach to 
addressing bacterial dysbiogenesis133,134 that leads to peri-implant disease with a shortening 
of the useful life of dental implants. With over 3 million implants placed in the US alone 
and growing by 500,000 implants/year 59, a reduced service life ending in implant failure 
will adversely impact public health. The rapid (two minute) delivery of antimicrobial 
bifunctional peptide films was tested on dental implant surfaces mimicking the application 
sequence necessary for re-treatment of peri-implantitis in a dental office 104. The designed 
functional peptides consisted of three domains, from the N'-terminus: titanium binding, 
spacer and antimicrobial.  
While the antimicrobial peptides were varied, the binding and spacer domains were 
kept constant with the goal of demonstrating that a computational approach can predict the 
antimicrobial properties of the resulting bifunctional peptide films. The percentage of a-
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helicity of the bifunctional peptides and their individual constituting domains were 
computationally predicted by the Chou-Fasman algorithm. The peptides were further 
analyzed using chimera secondary structure models and these secondary structure 
predictions were compared experimentally using CD spectroscopy. This predictive design 
approach considered the structure and function of the entire bifunctional peptide molecule. 
Three design methods were used here, namely sequence-based, de novo modeling, and 
experimental evaluation; all indicated that peptide incorporating the AMPA anti-microbial 
domain had greater helical content than the one containing the GL13K antimicrobial 
domain. This prediction was confirmed by the backbone dynamic data. This ensemble of 
structural analysis techniques formed the basis for the prediction that TiBP-AMPA would 
functionally outperform TiBP-GL13K as an antimicrobial peptide film. In particular, 
amphipathic and a-helicity were shown to be more prominent in ordered regions, which 
contribute to greater antimicrobial peptide film activity. The bifunctional peptides were 
evaluated experimentally for their potential to prevent and treat peri-implant disease. The 
bifunctional peptides were delivered in the clinically relevant manner (2 minute binding 
period), under competition with serum proteins. Their mechanical durability was tested, 
and they were empirically challenged with bacteria to confirm our computational 
predictions. The peptide films have been shown capable of rebinding ability through up to 
five cycles of bacterial fouling, cleaning and reapplication. These results demonstrate the 
success of our computational design approach and suggest that the TiBP-AMPA peptide 
has strong potential as a treatment for peri-implant disease due to its ability mitigate 






The hydrophobicity analyses of the bifunctional peptides were carried out using the 
antimicrobial peptide database calculator and predictor tool. TiBP-AMPA has a 
hydrophobic ratio of 30% with 10 hydrophobic residues aligned along the same surface of 
the a-helix. TiBP-GL13K revealed a hydrophobic ratio of 26%, slightly less than TiBP-
AMPA with only 5 hydrophobic residues aligned on the same surface. 
 
Figure 3-8: Bifunctional peptide hydrophobicity analysis using the Antimicrobial Peptide Database (APD) 






APD Total Defined Hydrophobic Ratio: 30%
APD Total Defined Hydrophobic Ratio: 26%
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Table 3-4: The minimum inhibitory concentration of the AMP domain in isolation. Peptides requiring 
amidation at the C'-terminus (GL13K and TiBP-GL13K) were synthesized using Rink-amide resin.  
 
 
Table 3-5: Fluorescence image quantification for percentage surface coverage of the images using ImageJ 
software. Reproduced from Wisdom, C.; Chen, C.; Yuca, E.; Zhou, Y.; Tamerler, C.; Snead, M. L., 










The rising use of dental implants has increased the prevalence of peri-implant 
disease that shortens their useful life. A growing view of peri-implant disease suggests that 
plaque accumulation and microbiome dysbiogenesis triggers a host immune inflammatory 
response destroying soft and hard tissues supporting the implant. The incidence of peri-
implant disease is difficult to estimate, but with over 3 million implants placed in the US 
alone, and the market growing by 500,000 implants/year such extensive use demands 
additional interceptive approaches. We report a water-based, non-surgical approach to 
address peri-implant disease using a bifunctional peptide film, which can be applied during 
the initial implant placement and later, reapplied to existing implants to reduce bacterial 
growth. Bifunctional peptides are based upon a titanium binding peptide (TiBP) optimally 
linked by a spacer peptide to an antimicrobial peptide (AMP). Dental implant surfaces 
covered with a bifunctional peptide film kills bacteria. Further, using a simple protocol for 
cleaning implant surfaces fouled by bacteria, the surface can be effectively re-coated with 
TiBP-AMP to regain an antimicrobial state. Fouling, cleansing, re-binding was confirmed 
for up to four cycles with a minimal loss of binding efficacy. Rebinding after fouling of a 
                                               
 
 
* Wisdom C, Chen C, Yuca E, Zhou Y, Tamerler C, Snead ML. Repeatedly Applied 
Peptide Film Kills Bacteria on Dental Implants. JOM. 2019.  
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water-based film extends control over the oral microbiome composition providing a novel 





There is a continuing need to improve patient treatment based on the therapeutic 
advantages offered by titanium dental implants. However, a complex biofilm rapidly forms 
on the surface of any dental implant once it is placed in the oral cavity. Within several 
weeks, the biofilm consists of the typical subgingival bacterial species including keystone 
periodontal pathogens such as P. gingivalis, A. actinomycetemcomitans, T. forsythia, T. 
denticola, and P. intermedia 135. The relative abundance of commensal bacterial species to 
periodontal pathogens shifts with dysbiosis and too often induces the host to mount an 
inflammatory response leading to peri-implant diseases starting with peri-implant 
mucositis and ending with peri-implantitis, resulting in the loss of soft and hard tissue 
anchoring the implant in the jaw and thus threatening the implant’s useful life. 
The expanded use of implants in dental treatment coupled with the rising 
prevalence of peri-implant disease threatens to shorten implant life and lead to implant 
failure in increasing numbers of patients 65,66. Recent consensus on peri-implant disease 
points to plaque accumulation and microbial dysbiogenesis as the major factors triggering 
the host immune inflammatory response 67-69. Millions of implants are placed yearly around 
the world, with 3 million placed in the US alone and rising at 500,000/annum 59. Reduced 
service life and eventual implant failure will therefore have a growing adverse impact on 
public health with an increase in health care cost. On the other hand, an effective treatment 
for peri-implant disease would make the benefits of implants available to a wider-group of 
patients in need 136,137. 
Despite a high success rate, within 5 years of placement, a small percentage (4-8%) 
of implants fail 8-10 and a higher percentage fail in patients with chronic illness, advanced 
age and/or poor periodontal health 137-140. The Cochrane meta-analysis report estimated the 
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incidence of peri-implantitis as 1.6% after 3 years and 5.5% at 10 years 141,142. In contrast, 
Derks and colleagues placed the incidence of peri-implantitis at ~14.5% after 9 years of 
service 143, while others identified clinically significant, non-linear bone loss as early as 
after 3 years of function in more than ~80% of patients 143. With implant use growing, 
increasing implant loss has a profound financial health care cost with the potential loss of 
public confidence in the dental profession.  
There is currently no definitive means for controlling and eliminating the bacterial 
biofilm on implants 75,144,145. Current state-of-the art treatments for implants are similar to 
those for periodontal disease and include mechanical debridement and/or medicinal means 
intended to retard the biofilm. For implant surfaces, these include: abrasive cup polishing; 
abrasive air blasting; titanium brushes with cleansing agents such as sodium hypochlorite 
or povidone-iodine; chlorohexidine rinses; antibiotics; and antimicrobials. Each treatment 
can be used alone or in concert by dental professionals. Successful treatment for peri-
implant disease must also recognize the need to maintain biocompatibility, osteogenic 
competency and cell viability at the implant surface to obtain favorable host cell responses 
144-146. Thus, a commonly held goal remains to control the oral microbiota in order to 
arrest/slow hard and soft tissue destruction by the host inflammatory response.  
There have been numerous attempts to boost implant surface performance with 
biologically active signals 50,103,147-152. However, the majority of them have required passive 
absorption or chemical coupling to the surface 153-155. Absorption leads to leaching and 
poor performance. Covalent coupling also has limited success because coupling these 
agents (e.g., thiols, carboxylic acids, hydroxyl, guanidines, and amines) create hostile 
environments to bioactive molecules, leading to loss of bioactivity 153,156 and/or incorrect 
display of the bioactivity to the cellular environment. Moreover, these hostile coupling 
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environments can be used only during manufacturing and not at recall appointments, long 
after placement, when the longevity of the implant is threatened. Ideally, both strong 
affinity to the implant surface and maintenance of the antimicrobial state are required.   
Peri-implantitis has become a growing concern in the community due to the 
increasing popularity of dental implants to restore form and function. Because at present, 
none of the non-surgical treatments result in a superior outcome, there is a lack of 
consensus with respect to predictable treatments for peri-implantitis, making treatment 
choices all but unmanageable for clinicians and patients. With the number of dental 
implants continuing to rise, there is an urgent need to identify a strategy that can further 
slow or even prevent peri-implantitis. Successful approaches will require novel and rational 
engineering design that can leverage the multi-faceted characteristics of biomolecules, as 
well as providing structural and functional properties at the material-tissue interfaces 157,158.  
Using a combination of experimental and computational bioengineering 
approaches we engineered a bifunctional peptide to provide a biocompatible, water-based, 
easy-to-apply, durable, peptide film that possesses antimicrobial activity. The bifunctional 
peptide can be repeatedly applied at recall appointments for continued treatment of peri-
implantitis to extend implant longevity. Reapplication offers a safe, inexpensive, water-
based bifunctional peptide film to treat existing implants at recall appointments to arrest 
disease progression as a viable peri-implantitis treatment strategy compared to current state 




MATERIALS AND METHODS 
Synthesis and Purification of Bifunctional Peptides 
Peptides were produced with an AAPPTec Focus XC automated solid phase peptide 
synthesizer using standard Fmoc chemistries and Wang resins. To remove the Fmoc 
protecting group, Wang resins preloaded with the first amino acid protected by a Fmoc 
group were treated with 20% piperidine in dimethylformamide (DMF). Fmoc deprotection 
was monitored by UV-absorbance and the deprotected resin was then washed with DMF 
to remove piperidine. Modified amino acids with protected side chains and Fmoc were 
solubilized in DMF at a concentration of 0.2M and added in 7-fold excess. In a separate 
measuring vessel, amino acids in solution were activated with 0.4M O-benzotriazole-
N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) in DMF and 1M 4-
methylmorpholine (NMM). The activated amino acid was then added to the reaction vessel 
and mechanically mixed under nitrogen gas for 45 minutes to couple the amino acid to the 
resin. Double-coupling was used for each amino acid in the sequences. After amino acid 
addition, the resin was washed with DMF and the protocol applied again for each 
subsequent amino acid.  
Following synthesis, the resins with synthesized peptides were dried with ethanol 
to remove residual DMF. The peptides were cleaved from the resin and the side-chains 
were deprotected using Reagent K (TFA/thioanisole/H2O/phenol/ethanedithiol 
(87.5:5:5:2.5)) and precipitated by cold ether. Crude peptides were purified with RP-HPLC 




Minimum Inhibitory Concentration (MIC) 
The MIC of TiBP-AMP was determined spectrophotometrically against S. mutans 
bacteria. Bacteria were cultivated and grown to mid-log phase. Serial dilutions, beginning 
at 256µM peptide concentration, were added to wells containing a final bacterial 
concentration of 1x107 CFU/mL in a 96 well plate and grown at 37°C for 24 hours. 
Absorbance at 600nm was monitored using a Cytation3 microplate reader. Control samples 
consisted of 1x107 CFU/mL bacteria only.  
 
Titanium Implant Disc Preparation 
Coin-shaped titanium implant discs, 10mm in diameter and 0.5mm thick, made 
from grade 4 titanium (USC Engineering Shop) were lap polished and grit blasted with 
180-220 micron titanium dioxide particles and cleaned following a published protocol 56. 
Briefly the cleaning protocol was to sonicate the discs in water, 70% ethanol, 40% sodium 
hydroxide, 50% nitric acid followed by rinsing with water and autoclaving prior to use.  
 
Bacterial Culture and Maintenance 
Streptococcus mutans ATCC 700610 was cultured according to the ATCC protocol 
in Brain Heart Infusion (BHI) broth (BD Difco). Several drops of rehydrated frozen stock 
of the bacteria were streaked on a BHI agar plate and incubated for 24 hours at 37°C and 
5% CO2. A single colony was removed from the agar plate and used to inoculate 5 mL of 
appropriate media followed by incubation overnight. Bacteria were grown to mid-log phase 




Bifunctional Peptide Binding on Titanium Discs   
New, sterile titanium discs were functionalized with bifunctional peptides by 
incubation of the disc with a peptide solution at 37°C. Specifically, 100μL of a 100µM 
concentration of bifunctional peptide for TiBP-AMP and C-AMP. Following incubation 
the discs were washed in a 24 well-plate by pipetting 400μL of DI onto the wall of a well 
containing the disc and then removing the H2O. Each disc was washed three times. The 
same procedure was repeated for the re-binding step for disc fouled/cleaned of bacteria.  
 
Fluorescent Imaging for Peptide Binding 
Peptide binding was evaluated by pipetting 20μL of Pierce fluorometric peptide 
labeling reagent directly onto the previously peptide film coated disc surface and 
incubating at room temperature, protected from light for five minutes. The discs were 
washed by holding the disc with forceps and pipetting water at a 45° angle, allowing the 
water to flow across the disc face. The discs were transferred to glass microscope slide, 
inverted, and imaged using an inverted fluorescent microscope (Zeiss Axioplus). The 
fluorescent images were saved both as a 2D representation, and a 3D representation in 
which the z-axis height corresponds to fluorescent intensity. Peptide binding was 
quantified as percent surface coverage using ImageJ software version 1.52a.  
 
Peptide Film Antibacterial Function on Titanium Discs 
Peptide functionalized discs were evaluated for antibacterial efficacy against S. 
mutans using the BacLight Live/Dead assay kit to differentiate living from dead bacteria 
present on the disc surface with selected bifunctional peptides compared to a water control. 
S. mutans (ATCC 700610) bacteria were grown and cultivated according to ATCC 
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protocols. 400μL of 1x107 CFU/mL S. mutans bacteria were incubated with the 
functionalized discs for 4 hours, then washed with 0.85% NaCl, according to manufacture 
recommendations, to remove any phosphates that could interfere with the Live/Dead stains. 
A solution of 30% stain (1:1 ratio of PI to SYTO9) in 70% 0.85% NaCl solution was used 
to stain bacteria on the disc surface. The discs were then transferred to a glass microscope 
slide and inverted for fluorescence microscopy. Images of five unique locations on the 
discs were collected with 10X magnification.  
 
Implant Disc Cleaning for Rebinding 
Discs were cleaned to remove bacteria, peptide and salts using a method that is 
common to implant retreatment visit. An electric toothbrush with a round head slightly 
larger than the diameter of the disc was secured in a laboratory stand. A Petri dish filled 
with peri-plast wax was used as a base for insertion of 30 gauge needles in a triangle 
configuration surround the disc to prevent motion of the disc when the electric toothbrush 
was applied with 100g of force 10 Cm from the secured pivot point. A 1:10 solution of 
sodium hypochlorite was pipetted into the Petri dish and the disc was brushed for 2 minutes 
and then removed and washed thoroughly with water. The disc was then air dried in a 
sterile laminar flow hood in preparation of peptide rebinding. The rebinding protocol is 
identical to the initial binding protocol. 
 
Retreatment Cycle Binding and Reapplication 
A solution of 33µM of TiBP-AuBP in phosphate buffered saline was pipetted onto 
a titanium disc and incubated at room temperature for one hour. Discs were washed once 
with DI H2O and then dried at room temperature. A solution of 50 nm gold nanoparticle 
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(AuNP) (Ted Pella Inc, USA) was incubated at room temperature on the peptide-
functionalized disc for 20 minutes. The discs were washed once with DI H2O and dried at 
room temperature. Next, a solution of 8 µM green fluorescent protein-gold binding peptide 
fusion (GFPuv-AuBP) was incubated on the surface for 20 minutes, washed, dried and 
imaged using a fluorescence microscope (Zeiss Axioplus). The same procedure was 
applied for four repetitions of fouling/cleansing. All images were analyzed with ImageJ 
software (version 1.52a). 
 
Surface Profilometry 
3D surface measurements of the discs were visualized using a white light 
profilometer (Veeco Wyko NT 1100 Optical Profiler). Pictures were taken at 5x, 10x and 
50x magnification. Non-over-lapping pictures were taken of the disc. In order to obtain 
images from the same disc coordinates, a grid was etched onto a glass slide that repeatedly 
orients the disc in the same orientation and position. The profilometer was then 
manipulated to ensure the same region of the disc is imaged for consistency and 
reproducibility.  
 
De Novo Peptide Structure Prediction and 3D Model Generation from Amino Acid 
Sequence 
The de novo 3D structural modeling approach available through the online service, 
PEP-FOLD 3.5 was implemented to generate PDB models for the five best models of each 
bifunctional peptide amino acid sequence [4]. PEP-FOLD 3.5 generates 3D structural 
conformations of linear peptides between 5-50 amino acids and provides PDB models for 
the 5-best structures. PEP-FOLD 3.5 generates peptide structures by assigning one of 27 
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structural alphabet (SA) terms to fragments of four amino acids overlapping by three. The 
SA generalizes the secondary structure by assigning geometric descriptors emitted by the 
Hidden Markov model described by Maupetit, et. al. [5]. 3D models are then generated 
from the fragments using a course grained representation and refined by 30,000 Monte-
Carlo steps. The chimeric peptide sequences were input into the PEP-FOLD 3.5 online 
service and 200 simulations were run assuming aqueous conditions and neutral pH. Once 
generated, the models were clustered and sorted using sOPEP (Optimized Potential for 
Efficient Structure Prediction) [7].  None biased modeling was applied.  
 
3D Model Visualization and Recoloring 
Protein Data Bank (PDB) files containing the secondary structure models generated 
by PEP-FOLD 3.5 were visualized and further analyzed by UCSF Chimera [8]. The 
structures were colored according to the peptide domains comprising the bifunctional 
peptides. The first functional domain was colored blue, the spacer was colored black, and 
the second functional domain was colored red. The structures were oriented so that the first 
functional domain was located at the bottom. The surface was added to the ribbon structure 
and a transparency of 80% was applied.  
 
RESULTS 
Antibacterial Activity in Solution 
The bacterial growth curves of S. mutans bacteria grown in the presence of serial 
dilutions of TiBP-AMP are depicted in Figure 4-1. The minimum concentration of TiBP-
AMP to inhibit S. mutans bacterial growth was found to be 64µM. The lowest 
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concentration evaluated, 8µM showed no bacterial inhibition, and in contrast, 256µM 
resulted in no growth of S. mutans. 
 
Figure 4-1:MIC of TiBP-AMP. Concentration of TiBP-AMP peptide in solution required to inhibit 
bacterial growth of Streptococcus mutans. Growth was measured every 30 min for 24 hours by absorbance 
at 600 nm and plotted as growth curves representing the increase of bacteria over time. The inhibitory 
concentration for TiBP-AMP was determined to be 64 μM.  
 
Implant Disc Preparation and Cleansing 
Discs were cleaned with a method common to periodontal therapy 159,160 and one 
that does not adversely affect clinical attachment. Hypochlorous acid (NaOCl) and a rotary 
electric toothbrush were used as a clinically relevant cleaning method to allow a rebinding 




Binding and Re-binding of the Bifunctional Peptide 
The top panels of Figure 4-2 depict TiBP-AMP and Control-AMP (AMP without 
the TiBP domain) binding on titanium discs. Binding was quantified as a percent surface 
coverage and determined to be 46.8% for TiBP-AMP and 0.2% for the Control-AMP 
(Table 4-1). Re-binding following bacterial fouling and a clinically relevant cleaning 
procedure is shown in the middle panels of Figure 4-2. The cleaned disc was recoated with 
the same peptides and surface coverage for TiBP-AMP was determined to be 28.5% (Table 
4-1) compared to 0.2% for Control-AMP (Table 4-1). After bacterial fouling, cleaned discs 
retained 60% of the original binding capacity. The absence of binding for the control 
bifunctional peptide to the cleaned discs demonstrates scant amounts of non-specific 
adherence of the peptide to bacterial debris.  
 
Antibacterial Functionalization on Implant Discs 
The discs were purposely inoculated with S. mutans to represent implant fouling in 
order to evaluate peptide film surface coverage for dental implant surfaces. The lower 
panels of Figure 4-2 show the difference in antibacterial properties between discs treated 
with the TiBP-AMP versus Control-AMP. The percent surface coverage of dead bacteria 
on the TiBP-AMP disc was 19.3% compared to 0.2% for the control (Table 4-2). There 
was a significant difference of 53.3% living bacteria on the control disc compared to 1.7% 
on the disc TiBP-AMP (Table 4-2).  
 
Retreatment Cycle Binding and Reapplication 
Figure 4-3 shows binding on titanium discs fouled up to 4 times. The bifunctional 
peptide, TiBP-AuBP was disclosed by incubation with gold nano-particles that bound to 
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the AuBP (gold binding peptide). A fusion protein with green fluorescent protein GFPuv-
AuBP was then used to identify peptides via the GFP fluorescent signal that were bound to 
the AuNPs on TiBP-AuBP film attached to the titanium disc surface. Minimal to no 
fluorescence was observed for bare titanium discs, for discs functionalized with TiBP-
AuBP+AuNP, and no signal for discs functionalized with GFPuv-AuBP fusion protein only. 
The fluorescence of the discs was measured using ImageJ and the results for TiBP-AuBP 







Figure 4-2: Fluorescence microscopy images of bifunctional peptide binding and antimicrobial activity on 
titanium implant discs. Binding and rebinding with 100 μM of either bifunctional peptide was identified 
with a fluorescent dye. In the larger 3D images, the z-axis height corresponds to fluorescence intensity, 
while the smaller insert images correspond to 2D representations. Rebinding was performed on a once-
fouled S. mutans implant disc. The antibacterial properties of the bifunctional peptides against S. mutans 
are shown using a Live/Dead (L/D) assay to differentiate live (green) from dead (red) bacteria present on 
the disc surface. Scale bar = 100 μm. 
 
De Novo Secondary Structure Generation 
Secondary structures were generated for the three bifunctional peptides studied 
herein. The secondary structures for TiBP-AMP, Control-AMP, and TiBP-AuBP are 
depicted in Figure 4-4. The domains were recolored, so that blue indicates the first 
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functional domain (TiBP or Control), black indicates the spacer, and red indicates the 
second functional domain (AMP or AuBP). 




Titanium Disc Surface Topography 
Surface topography characterization is summarized in Figure 4-5. The average 
roughness, RMS, and range are reported for bacteria fouled titanium discs after cleaning 
and for the TiBP-AMP after re-binding to the titanium discs. There was no significant 
change in the surface topography characteristics among the samples.  
 
Table 4-2: Quantitative results from the live/dead images of S. mutans bacteria on implant discs treated 






Figure 4-3: Fluorescence microscopy images of binding/rebinding on implant discs fouled multiple times 
by bacteria. A bifunctional peptide composed of the titanium binding peptide (TiBP) and a gold binding 
peptide (AuBP) was bound to the titanium disc and to gold nanoparticles (AuNP). A fusion protein, green 
fluorescent protein (GFPuv), fused to AuBP was subsequently bound to the AuNP immobilized on the 
titanium surface by the TiBP-AuBP bifunctional peptide. Schematics at the top of the figure represent the 
layer-by-layer assembly procedure used for imaging. After each addition, the surfaces were washed to 
remove any non-specifically bound peptides. Fluorescence images were obtained at each step and are 
shown. The procedure was repeated for multiple rounds of fouling to model multiple retreatment visits for 




Table 4-3: Fluorescence microscopy image quantification by measuring the percentage surface coverage of 




Figure 4-4: De novo secondary structures of the bifunctional peptides studied. The structures have been 
recolored according to the domains in each bifunctional peptide. In all structures, the titanium binding 





Figure 4-5: Surface topography characterization by optical profilometry . Optical profilometry images were 
collected and analyzed for sterile discs (Sterile), discs following bacterial fouling and the clinical cleaning 
procedure (Post Clean), and TiBP-AMP rebound to the fouled and cleaned disc surface. The lack of 
statistical difference (n = 5) for the average, RMS, and range of the roughness indicates that the surface 




In Solution Antibacterial Activity 
The antibacterial activity of a TiBP-AMP was established. Critical to the success 
of the bifunctional peptide on the surface is the antimicrobial function of the AMP domain 
when joined to the anchoring domain created by a titanium binding peptide (TiBP) through 
an engineered spacer (Figure 4-4). The titanium binding peptide has been previously 
reported to effectively serve as a self-assembling anchor for bifunctional peptides 50,103,161. 
Similarly, we have previously established the importance of engineering the design of the 
spacer to optimize the function of the antimicrobial peptide domain in the bifunctional 
peptide construct 161. The spacer serves as a link between two functional domains that is 
designed to preserve the secondary structure for each individual domain, a parameter that 
is tightly linked to antimicrobial function. Here, a novel AMP domain obtained from the 
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literature was linked to the TiBP through a “spacer5” to create a bifunctional peptide as 
previously studied 161. However, the antimicrobial, AMPA has not been used in a 
bifunctional peptide design and was selected through a rational design process based on 
previously determined antimicrobial “rules” 50. The bifunctional peptide can be evaluated 
against other oral pathogens with significant influence in the initiation and progression of 
peri-implant disease. Other keystone periodontal pathogens that could be evaluated 
include P. gingivalis, A. actinomycetemcomitans, T. forsythia, T. denticola, and P. 
intermedia. As more data is obtained on the function of this peptide construct against oral 
pathogens, the same “rule” induction method can be applied to elucidate peptide secondary 
structure features that are predominant in effective peptides against bacteria in addition to 
S. mutans. The minimum inhibitory concentration for the TiBP-spacer5-AMPA 
bifunctional peptide was established at 64µM for an ATCC line of S. mutans (Figure 4-1).  
 
Binding and Re-binding of the Bifunctional Peptide 
TiBP-AMP is designed to incorporate a high-affinity titanium implant anchoring 
peptide with an antimicrobial peptide linked through a spacer designed to preserve the 
function of each peptide. The data demonstrates that the selected spacer design provides 
not only preserves antimicrobial activity, but also preserves robust anchoring activity to 
the implant surface through the TiBP domain as seen during repeated retreatment of 
cleansed bacteria fouled surfaces as would occur for implants already placed in the jaws 
(Figure 4-2, Table 4-1).  
TiBP-AMP can be repeatedly applied to a bacteria fouled implant surface to deliver 
antimicrobial properties to address the etiopathogenesis for peri-implant disease. In 
contrast, the Control-AMP (without TiBP) shows minimal absorption to the surface of 
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bacteria fouled and cleansed titanium discs (Figure 4-2, Table 4-1). Low binding to 
fouled/cleaned titanium surfaces finding indicates that peptide binding is not due simply to 
non-specific adherence/absorption to the implant surface, nor to any bacteria debris 
(biopolymers) retained on the fouled surface. The data demonstrates that using 
maintenance procedures known and followed at professional recall appointments 159,160, 
that currently available anti-microbial peptide design can be successfully re-applied and is 
anchored to the surface of a previously fouled and cleaned implant surface.   
 
Antibacterial Functionalization on Implant Discs 
Antibacterial function and titanium anchoring function were both demonstrated 
simultaneously on discs functionalized with TiBP-AMP when challenged with S. mutans 
bacteria. The TiBP-AMP film successfully demonstrated an antibacterial function with 
19.3% dead bacteria, compared to 0.2% for the Control-AMP. Additionally, the TiBP-
AMP peptide film was antibiofouling with 21% total surface coverage by bacteria (living 
and dead) compared to 54% with the control peptide treated disc. Bifunctional peptides 
have previously been used as antibacterial surface agents; however, we demonstrate 
antibacterial and antibiofouling activity following re-binding with a procedure that could 
clinically be performed during a professional retreatment appointment. This technology is 
an advancement in the field over passively absorbed molecules subject to leaching and 
poor performance challenges 50,103,147-152. A water-deliverery system for the bifunctional 
peptide completely eliminates the need for biologically hostile coupling environments 
typically required for chemically coupling the bioactive molecule 153-155. The capacity to 
deliver a water-based bifunctional peptide to implants that have been previously placed in 
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the jaw is a paradigm shift, allowing potentially limitless retreatment opportunities to 
control oral biofilms during the life of the implant.  
 
Retreatment Cycle Binding and Reapplication 
A novel method for disclosing peptide anchored on the implant surface was 
demonstrated in Figure 4-3. This method ensures specific identification of the bifunctional 
peptide of interest on a titanium surface prepared for integration with the bone. This 
technique also ensures that the bifunctional peptide, TiBP-AuBP alone was identified 
avoiding noise from non-specific interactions with bacterial biopolymers on the disc 
surface. The specificity of detection was preserved following bacterial fouling for up to 4 
cycles of fouling/cleansing. The quantitation of the peptides bound to the discs 
demonstrates that precise binding to the titanium surface is preserved. Furthermore, the 
data demonstrates that the amount of peptide bound generally increases slightly with each 
successive fouling cycle, with the exception of cycle 2. The demonstrated preservation of 
the TiBP to anchor to the surface strengthens the impact of this technology as a non-
surgical, water based retreatment option for peri-implant disease. Multiple retreatment 
procedures can be performed, extending the lifetime of the implant. 
 
De Novo Secondary Structure Generation 
The secondary structures generated demonstrate preservation of the a-helix 
character of the antimicrobial domain, which has previously been linked to antimicrobial 
function. The engineered spacer is critical to preserving the function of the antimicrobial 




Titanium Disc Surface Topography 
Titanium implant discs were prepared by grit blasted with 180-220 micron titanium 
dioxide particles 54-56,60 and sterilized by following a widely used protocol similar to that 
used by implant manufactures to create “active osteointegration” surfaces 60. 
Biocompatibility is an essential feature for all implant surfaces and preserving the surface 
properties is a mandatory design requirement. The average roughness, RMS and range 
parameters did not significantly change after fouling and cleaning for re-treatment, and 
after re-binding of the bifunctional peptide film (Figure 4-5). This result supports the 
advantage of this approach to not only create an antibacterial and anti-biofouling implant 
surface, but also one that is competent to support osteointegration and is similar to 
standards for surface topography currently favored by implant manufactures.  
 
CONCLUSION 
A water-based, non-surgical approach to address peri-implant disease using a 
bifunctional peptide film applied during the initial implant placement for new implants or 
at the time of retreatment for existing implants was demonstrated. Function of the TiBP 
and AMP domains linked by an engineered spacer in a bifunctional peptide was confirmed 
through identification of minimal inhibitory concentration in solution, as well as by surface 
antimicrobial activity. More so, this simple cleansing protocol likely preserved the 
biocompatibity of the titanium implant while reexposing the titanium surface after bacterial 
fouling to sufficiently permit rebinding of the bifunctional peptide. The re-bound 
bifunctional TiBP-AMP peptide film supported antibacterial and anti-biofouling activity 
over 4 fouling/cleaning cycles. This technology represents a paradigm shift in the 
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prevention of dental implant failure while adding to the range of bioactive molecules that 




CHAPTER 5 – CONCLUSION 
 
The use of titanium dental implants is increasing and consequently the prevalence 
of implant failure and resulting diseases such as peri-implant disease. The failure of 
implants due to untreated and unresolved peri-implant disease will adversely impact public 
health, trigger increased health care costs, and result in tooth loss contributing to mortality 
in an aging population. The overall aim of this thesis was to develop a bio-enabled peptide 
film approach to combat implant failure by designing and engineering bifunctional 
peptides. The bifunctional peptide joins two independent biologically functional peptide 
domains on a single polypeptide chain through an engineered amino acid spacer. In this 
thesis, titanium binding peptide (TiBP) and three unique antimicrobial peptides (AMPs) 
were joined through a novel engineered amino acid spacer, GSGGG.  
Several examples of bifunctional peptides on titanium medical implants can be 
found throughout the academic literature, with significant contributions coming from our 
group. Building upon the expertise demonstrated by our group to link RGD integrin 
binding peptide and antimicrobial peptides through a simple GGG spacer, this thesis 
demonstrates the importance of the spacer design by evaluating a longer and more rigid 
spacer, GSGGG. Peptide secondary structure is closely linked to function and preservation 
of the secondary structure of the functional domains is critical for peptide engineering. This 
understanding offers an opportunity to develop and engineer spacers tailored to improving 
bifunctional peptide efficacy. The bifunctional peptide evaluated in Chapter 2 of this thesis 
was composed of previously reported AMP and TiBP domains that were linked using the 
improved spacer design, Spacer5 (GSGGG). Computational and experimental peptide 
secondary structure studies revealed an improved conservation of the TiBP domain 
secondary structure and produced a higher percentage of 4- and 5-amino acid a-helix 
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structure with Spacer5 compared to the previously reported Spacer3. The addition of a 
serine and glycine in Spacer5 disrupted the a-helix at the spacer region and contributed to 
a shorter a-helix segment confined to the AMP domain. The bifunctional peptide with 
Spacer3 produced an a-helix structure that extended through the spacer and into the TiBP 
domain. Therefore, we hypothesized that Spacer5 would be more effective as a surface-
active antimicrobial based on the “rules” we previously generated for bifunctional peptides. 
The “rules” indicated that 4- and 5-amino acid a-helix structure is a key contributing 
feature to antimicrobial function.  
This hypothesis was tested by evaluating antimicrobial function in solution against 
S. mutans and S. epidermidis bacteria. S. mutans bacteria is common in dental implant 
infections, whereas S. epidermidis is common in orthopedic implant infections. The in-
solution results supported the hypothesis for bifunctional peptide antimicrobial 
effectiveness against S. mutans with a 3-fold decrease in the minimum concentration 
required to inhibit bacterial growth (MIC). However, the MIC for the bifunctional peptide 
with Spacer5 did not improve against S. epidermidis.  
Next, the hypothesis was tested by evaluating the bacterial attachment on titanium 
foils and stock titanium implant rods. The TiBP-Spacer5-AMP bifunctional peptide film 
compared to bare titanium foils reduced S. mutans and S. epidermidis attachment on the 
titanium foils by 6- and 33-fold, respectively. A more dramatic anti-biofouling effect was 
observed on the titanium implant rods with a 9-fold reduction in S. mutans bacterial 
attachment and a 48-fold reduction in S. epidermidis bacterial attachment.  
Finally, host fibroblast cell response to the bifunctional peptide film was evaluated 
on titanium foils and implant rods. Fibroblast cell attachment was similar on bare titanium 
foils and foils with the bifunctional peptide film. However, the fibroblast cells attached to 
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the bifunctional peptide film coated foil spread more and showed improved viability 
measured by an MTT metabolic assay. On the titanium implant rods, the bifunctional 
peptide film resulted in greater numbers of cell attachment, spreading, and viability. This 
promising finding demonstrated that bifunctional peptide films offer not only the 
opportunity to prevent bacterial attachment, but to improve host cell attachment on 
clinically available titanium implant materials.  
The results from Chapter 2 of this thesis provided a foundation and informed the 
direction for the rest of the work contained here. The key conclusions from Chapter 2 were 
confirmation of an improved spacer design that segregates antimicrobial and binding 
domain secondary structure, while allowing the two bio-functions to exist on the same 
polypeptide chain. This improved spacer design resulted in an increase in antimicrobial 
function in-solution and on the implant surface against S. mutans. The remainder of the 
thesis focuses on addressing prevention of infection and treating infection on dental 
implants where S. mutans is a common bacteria leading to infection and implant failure. 
Further, the evaluation of host fibroblast cell response supports using bifunctional peptide 
films to combat bacterial infection, while allowing host cell attachment, spreading, and 
viability that will be critical to the long-term integration and survivability of the implant. 
The findings in Chapter 2 provided additional support for the “rules” previously developed 
and aided in the design of bifunctional peptides that are presented in Chapter 3.  
The focus of Chapter 3 was the rational design of bifunctional peptides with TiBP 
and Spacer5 that incorporated additional antimicrobial peptide domains available in the 
antimicrobial peptide database (APD). Antimicrobial peptides are promising alternatives 
to supplement or replace the current clinical standard for infection prevention and 
treatment, antibiotics. Concern due to the prevalence and difficulty in treating emerging 
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antibiotic resistant bacterial strains has spurred efforts by funding agencies to invest in 
antimicrobial research and development. Development of a rational design approach for 
bifunctional peptides is an opportunity to incorporate AMP sequences as they are 
discovered with improved antimicrobial efficacy, favorable host cell response, resistance 
to proteolytic degradation, and to tailor the bifunctional peptide to specific bacteria for a 
given application. There are currently over 3600 AMPs that have been discovered in the 
natural world or through in silico design. In Chapter 3, we selected two AMPs from the 
APD database, GL13K and AMPA, with proven antimicrobial activity against common 
dental pathogens and incorporated them into bifunctional peptides through a rational design 
approach considering the sequence-structure-function relationships. The predictive design 
approach consisted of three methods: 1) sequence-based, 2) de novo modeling, and 3) 
experimental evaluation.  
The sequence-based approach used a computationally efficient well-established 
algorithm based on the probability of an amino acid to exist in a given secondary structure 
called the Chou-Fasman algorithm. The Chou-Fasman algorithm indicated that TiBP-
Spacer5-AMPA would contain 69% a-helix structure compared to only 50% for TiBP-
Spacer5-GL13K. Based on our “rules” for bifunctional peptide design and the correlation 
of a-helicity and antimicrobial function, the sequence-based prediction would indicate that 
TiBP-Spacer5-AMPA would have a greater antimicrobial activity. Additionally, the 
hydrophobicity and ampipathicity information determined from the amino acid sequences 
were studied using two tools. The Calculate and Predict tool from the APD indicated a 
hydrophobic ratio of 30% for TiBP-Spacer5-AMPA compared to 26% for TiBP-Spacer5-
GL13K. Generation of helical wheels showed that TiBP-Spacer5-AMPA has 10 
hydrophobic residues aligned along the same surface of the a-helix in the antimicrobial 
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peptide domain compared to only 5 for TiBP-Spacer5-GL13K. Hydrophobicity and 
ampipathicity are believed to allow the AMP to penetrate a bacterial lipid bilayer and 
disrupt the cell membrane leading to bacterial death. These analyses further support and 
add additional evidence for our prediction that TiBP-Spacer5-AMPA would be a more 
effective antimicrobial. A prediction of backbone dynamics from the amino acid sequence 
using DynaMine indicate conservation of the intrinsically disordered peptide region of the 
TiBP. These studies of the backbone dynamics indicate availability of the TiBP to interact 
with the implant surface for effective anchoring, while more ordered structure exists in the 
AMP domains for effective bacteria killing.  
De novo modeling of the bifunctional peptides revealed two a-helixes joined by a 
turn in the AMPA domain compared to a short a-helix in the GL13K domain. This finding 
was of particular interest since we have established that short 4- and 5- amino acid a-helix 
features are important for antimicrobial function in bifunctional peptides. TiBP-Spacer5-
AMPA containing two short helix structures could provide additional interaction and 
penetration of the bacterial cell membrane making it more effective at killing compared to 
the single feature in GL13K. The computational models were further studied using 
Chimera and the percent identity or similarity of the TiBP and AMP domains incorporated 
in bifunctional peptides compared to the independent domains was determined. The TiBP 
domain was 91.7% conserved in both bifunctional peptides. However, the AMPA domain 
was only 60% conserved compared to 92.3% for the GL13K domain. This result indicates 
that further work could be done to improve the spacer region linking TiBP and AMPA to 
preserve the secondary structure of the AMPA which is linked to antimicrobial function.  
Finally, the bifunctional peptides were evaluated experimentally for their potential 
to prevent and treat peri-implant disease. The bifunctional peptides were delivered on a 
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clinically relevant time scale of two minutes to achieve binding and under competition with 
serum proteins. Both bifunctional peptides achieved near 100% binding within two 
minutes. In competition with serum proteins, TiBP-Spacer5-AMPA achieved 80% surface 
coverage compared to 73% surface coverage achieved by TiBP-Spacer5-GL13K. 
Mechanical durability of the bifunctional peptide films was tested by subjecting the peptide 
films to brushing with an electric toothbrush for one minute. TiBP-Spacer5-AMPA was 
better retained on the implant disc with 75% remaining after brushing compared to 27% of 
TiBP-Spacer5-GL13K remaining. This suggests that the TiBP-Spacer5-AMPA 
bifunctional peptide film is more durable in addition to the predicted antimicrobial 
advantages. Durability is critical in a clinical environment as the implant surface would be 
brushed and cleaned to aid in bacterial or food debris removal.  
Two evaluations of the bifunctional peptide films in the presence of bacteria were 
conducted. First, a FITC label on the peptides was used to visualize the amount of peptide 
remaining on the surface after 24-hour challenge with S. mutans. 84% of the surface 
remained covered by the TiBP-Spacer5-AMPA film compared to only 60% for TiBP-
Spacer5-GL13K. Finally, the antimicrobial efficacy on the implant disc surface was 
evaluated by staining dead bacteria with PI dye. The percentage of dead bacteria on implant 
discs with TiBP-Spacer5-AMA was 46% compared to 10% for TiBP-Spacer5-GL13K. 
These results demonstrate the success of our computational design approach and suggest 
that the TiBP-AMPA peptide has strong potential as a treatment for peri-implant disease 
due to its ability to mitigate bacterial biofilm formation. 
In Chapter 4, we further evaluated TiBP-Spacer5-AMPA as a treatment and re-
treatment option for peri-implantitis. We report a water-based, non-surgical approach to 
address peri-implant disease using a bifunctional peptide film, which can be applied during 
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the initial implant placement and later, reapplied to existing implants to reduce bacterial 
growth. The bifunctional peptide approach represents an improvement over non-specific 
binding of antimicrobials to the implant surface, as well as a water-based strategy that 
allows for retreatment without the harsh chemical treatment required for covalent 
immobilization of antibacterial agents on the implant surface. Further, we demonstrated a 
clinically relevant cleaning procedure for bacterial fouled discs using a rotary toothbrush 
that did not disrupt the titanium surface, thus preserving the biocompatibility of the implant 
material. We confirmed the surface topography preservation following fouling and 
cleaning using optical profilometry and did not observe a change in the average roughness 
of the implant surface. Our bifunctional peptide was able to re-bind to bacteria fouled and 
cleaned titanium implant discs up to four cycles with retention of 60% of the original 
binding capacity. Additionally, the antibacterial efficacy of the bifunctional peptide film 
re-bound to the fouled and cleaned implant surface was preserved.  
The technology addresses the continuing need to improve patient treatment based 
on the therapeutic advantages offered by titanium dental implants by presenting a solution 
for treatment of peri-implant disease by controlling or eliminating the bacterial biofilm on 
implants. In Chapter 2, we develop the importance of spacer engineering linking a TiBP 
and AMP and relate the improved spacer design capable of better segregating and 
preserving the structure of the binding and antimicrobial domains is critical for improving 
function of each domain in the bifunctional peptide platform. In Chapter 3, we design novel 
bifunctional peptides by incorporating more effective AMPs from the Antimicrobial 
Peptide Database using a rational design approach and show the predictive ability of using 
less resource and cost intensive computational methods to design improved bifunctional 
peptides. In Chapter 4, we demonstrate the bifunctional peptide film as a treatment and re-
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treatment option for new and already placed titanium dental implants with the capability 
of re-binding and bringing antimicrobial activity to the implant surface following bacteria 
fouling and a clinically relevant cleaning procedure. This technology represents a paradigm 
shift in the prevention of dental implant failure while adding to the range of bioactive 
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